<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/en/sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml">
<url><loc>https://epicentre.msf.org/</loc><changefreq>daily</changefreq><priority>1.0</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en" /></url>
<url><loc>https://epicentre.msf.org/publications/effect-previous-treatment-and-sputum-quality-diagnostic-accuracy-xpert-mtbrif</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effect-previous-treatment-and-sputum-quality-diagnostic-accuracy-xpert-mtbrif" /></url>
<url><loc>https://epicentre.msf.org/publications/predictors-delayed-culture-conversion-among-ugandan-patients</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/predictors-delayed-culture-conversion-among-ugandan-patients" /></url>
<url><loc>https://epicentre.msf.org/publications/high-hepatitis-e-seroprevalence-among-displaced-persons-south-sudan</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-hepatitis-e-seroprevalence-among-displaced-persons-south-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/different-origin-and-dispersal-sulfadoxine-resistant-plasmodium-falciparum-haplotypes</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/different-origin-and-dispersal-sulfadoxine-resistant-plasmodium-falciparum-haplotypes" /></url>
<url><loc>https://epicentre.msf.org/publications/trends-one-year-cumulative-incidence-death-between-2005-and-2013-among-patients</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/trends-one-year-cumulative-incidence-death-between-2005-and-2013-among-patients" /></url>
<url><loc>https://epicentre.msf.org/publications/antimicrobial-resistant-infections-among-postpartum-women-ugandan-referral-hospital</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antimicrobial-resistant-infections-among-postpartum-women-ugandan-referral-hospital" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-and-correlates-mrsa-and-mssa-nasal-carriage-ugandan-regional-referral</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-and-correlates-mrsa-and-mssa-nasal-carriage-ugandan-regional-referral" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-and-clinical-outcomes-children-treated-antiretroviral-therapy-four-african</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-and-clinical-outcomes-children-treated-antiretroviral-therapy-four-african" /></url>
<url><loc>https://epicentre.msf.org/publications/antimicrobial-resistance-west-africa-systematic-review-and-meta-analysis</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antimicrobial-resistance-west-africa-systematic-review-and-meta-analysis" /></url>
<url><loc>https://epicentre.msf.org/publications/protection-against-cholera-killed-whole-cell-oral-cholera-vaccines-systematic-review</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/protection-against-cholera-killed-whole-cell-oral-cholera-vaccines-systematic-review" /></url>
<url><loc>https://epicentre.msf.org/publications/estimating-hiv-incidence-using-cross-sectional-survey-comparison-three-approaches</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimating-hiv-incidence-using-cross-sectional-survey-comparison-three-approaches" /></url>
<url><loc>https://epicentre.msf.org/publications/combined-interventions-reduce-hiv-incidence-kwazulu-natal-modelling-study</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/combined-interventions-reduce-hiv-incidence-kwazulu-natal-modelling-study" /></url>
<url><loc>https://epicentre.msf.org/publications/prospective-cohort-study-feasibility-and-yield-household-child-tuberculosis-contact</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prospective-cohort-study-feasibility-and-yield-household-child-tuberculosis-contact" /></url>
<url><loc>https://epicentre.msf.org/publications/outcome-children-presumptive-tuberculosis-mbarara-rural-uganda</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outcome-children-presumptive-tuberculosis-mbarara-rural-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/quantitative-survey-health-and-violence-endured-refugees-during-their-journey-and</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/quantitative-survey-health-and-violence-endured-refugees-during-their-journey-and" /></url>
<url><loc>https://epicentre.msf.org/publications/vaccination-against-cholera-juba-authors-reply</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vaccination-against-cholera-juba-authors-reply" /></url>
<url><loc>https://epicentre.msf.org/publications/intermittent-preventive-treatment-malaria-among-children-refugee-camp-northern-uganda</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/intermittent-preventive-treatment-malaria-among-children-refugee-camp-northern-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/ciprofloxacin-contacts-cases-meningococcal-meningitis-epidemic-response-study-protocol</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ciprofloxacin-contacts-cases-meningococcal-meningitis-epidemic-response-study-protocol" /></url>
<url><loc>https://epicentre.msf.org/publications/retrospective-mortality-among-refugees-central-african-republic-arriving-chad-2014</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/retrospective-mortality-among-refugees-central-african-republic-arriving-chad-2014" /></url>
<url><loc>https://epicentre.msf.org/publications/seasonal-malaria-chemoprevention-successes-and-missed-opportunities</loc><lastmod>2019-02-16T16:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/seasonal-malaria-chemoprevention-successes-and-missed-opportunities" /></url>
<url><loc>https://epicentre.msf.org/publications/indirect-costs-underfunding-foreign-partners-global-health-research-case-study</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/indirect-costs-underfunding-foreign-partners-global-health-research-case-study" /></url>
<url><loc>https://epicentre.msf.org/publications/improving-rotavirus-vaccine-coverage-can-newer-generation-and-locally-produced</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/improving-rotavirus-vaccine-coverage-can-newer-generation-and-locally-produced" /></url>
<url><loc>https://epicentre.msf.org/publications/ideal-cardiovascular-health-and-carotid-atherosclerosis-mixed-cohort-hiv-infected-and</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ideal-cardiovascular-health-and-carotid-atherosclerosis-mixed-cohort-hiv-infected-and" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-control-strategies-and-behavioural-changes-elimination-ebola-lofa-county</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-control-strategies-and-behavioural-changes-elimination-ebola-lofa-county" /></url>
<url><loc>https://epicentre.msf.org/publications/shortened-multidrug-resistant-tuberculosis-treatment-settings-high-prevalence</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/shortened-multidrug-resistant-tuberculosis-treatment-settings-high-prevalence" /></url>
<url><loc>https://epicentre.msf.org/publications/severe-malnutrition-infants-displaced-mosul-iraq</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/severe-malnutrition-infants-displaced-mosul-iraq" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-and-effectiveness-rvsv-vectored-vaccine-preventing-ebola-virus-disease-final</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-and-effectiveness-rvsv-vectored-vaccine-preventing-ebola-virus-disease-final" /></url>
<url><loc>https://epicentre.msf.org/publications/using-simulation-aid-trial-design-ring-vaccination-trials</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/using-simulation-aid-trial-design-ring-vaccination-trials" /></url>
<url><loc>https://epicentre.msf.org/publications/incremental-yield-including-determine-tb-lam-assay-diagnostic-algorithms-hospitalized</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/incremental-yield-including-determine-tb-lam-assay-diagnostic-algorithms-hospitalized" /></url>
<url><loc>https://epicentre.msf.org/publications/outcomes-first-multidrug-resistant-tuberculosis-programme-kenya</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outcomes-first-multidrug-resistant-tuberculosis-programme-kenya" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-self-report-and-antiretroviral-detection-inform-estimates-antiretroviral</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-self-report-and-antiretroviral-detection-inform-estimates-antiretroviral" /></url>
<url><loc>https://epicentre.msf.org/publications/higher-risk-sexual-behaviour-associated-unawareness-hiv-positivity-and-lack-viral</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/higher-risk-sexual-behaviour-associated-unawareness-hiv-positivity-and-lack-viral" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-low-cost-heat-stable-oral-rotavirus-vaccine-niger</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-low-cost-heat-stable-oral-rotavirus-vaccine-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/outpatient-treatment-severe-acute-malnutrition-response-treatment-reduced-schedule</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outpatient-treatment-severe-acute-malnutrition-response-treatment-reduced-schedule" /></url>
<url><loc>https://epicentre.msf.org/publications/heat-stable-oral-rotavirus-vaccine</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/heat-stable-oral-rotavirus-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/cost-analysis-treatment-severe-acute-malnutrition-west-africa</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cost-analysis-treatment-severe-acute-malnutrition-west-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-antibodies-brucella-species-commercial-raw-bovine-milk-southwestern-uganda</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-antibodies-brucella-species-commercial-raw-bovine-milk-southwestern-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/detection-plasmodium-species-high-resolution-melt-analysis-dna-blood-smears-acquired</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detection-plasmodium-species-high-resolution-melt-analysis-dna-blood-smears-acquired" /></url>
<url><loc>https://epicentre.msf.org/publications/towards-more-accurate-hiv-testing-sub-saharan-africa-multi-site-evaluation-hiv-rdts</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/towards-more-accurate-hiv-testing-sub-saharan-africa-multi-site-evaluation-hiv-rdts" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-chest-radiograph-reading-and-recording-system-tuberculosis-hiv-positive</loc><lastmod>2019-02-16T16:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-chest-radiograph-reading-and-recording-system-tuberculosis-hiv-positive" /></url>
<url><loc>https://epicentre.msf.org/publications/guide-aid-selection-diagnostic-tests</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/guide-aid-selection-diagnostic-tests" /></url>
<url><loc>https://epicentre.msf.org/publications/designing-hiv-testing-algorithms-based-2015-who-guidelines-using-data-six-sites-sub</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/designing-hiv-testing-algorithms-based-2015-who-guidelines-using-data-six-sites-sub" /></url>
<url><loc>https://epicentre.msf.org/publications/hiv-misdiagnosis-sub-saharan-africa-performance-diagnostic-algorithms-six-testing</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/hiv-misdiagnosis-sub-saharan-africa-performance-diagnostic-algorithms-six-testing" /></url>
<url><loc>https://epicentre.msf.org/publications/response-comment-alert-not-alarmed-comment-towards-more-accurate-hiv-testing-sub</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/response-comment-alert-not-alarmed-comment-towards-more-accurate-hiv-testing-sub" /></url>
<url><loc>https://epicentre.msf.org/publications/diagnostic-accuracy-vikiar-rota-adeno-and-premiertm-rotacloner-tests-detection</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/diagnostic-accuracy-vikiar-rota-adeno-and-premiertm-rotacloner-tests-detection" /></url>
<url><loc>https://epicentre.msf.org/publications/spatial-and-temporal-dynamics-superspreading-events-2014-2015-west-africa-ebola</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/spatial-and-temporal-dynamics-superspreading-events-2014-2015-west-africa-ebola" /></url>
<url><loc>https://epicentre.msf.org/publications/two-phase-approach-identification-refugees-priority-need-mental-health-care-lebanon</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/two-phase-approach-identification-refugees-priority-need-mental-health-care-lebanon" /></url>
<url><loc>https://epicentre.msf.org/publications/immunogenicity-and-protection-single-dose-internationally-available-killed-oral</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/immunogenicity-and-protection-single-dose-internationally-available-killed-oral" /></url>
<url><loc>https://epicentre.msf.org/publications/ensuring-access-oral-cholera-vaccine-those-who-need-them-most</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ensuring-access-oral-cholera-vaccine-those-who-need-them-most" /></url>
<url><loc>https://epicentre.msf.org/publications/drivers-rift-valley-fever-emergence-mayotte-bayesian-modelling-approach</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/drivers-rift-valley-fever-emergence-mayotte-bayesian-modelling-approach" /></url>
<url><loc>https://epicentre.msf.org/publications/el-nino-and-shifting-geography-cholera-africa</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/el-nino-and-shifting-geography-cholera-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/trauma-and-resilience-among-children-3-6-years-old-three-neighborhoods-port-au-prince</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/trauma-and-resilience-among-children-3-6-years-old-three-neighborhoods-port-au-prince" /></url>
<url><loc>https://epicentre.msf.org/publications/improving-specificity-plasmodium-falciparum-malaria-diagnosis-high-transmission</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/improving-specificity-plasmodium-falciparum-malaria-diagnosis-high-transmission" /></url>
<url><loc>https://epicentre.msf.org/publications/carriage-prevalence-and-serotype-distribution-streptococcus-pneumoniae-prior-10-valent</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/carriage-prevalence-and-serotype-distribution-streptococcus-pneumoniae-prior-10-valent" /></url>
<url><loc>https://epicentre.msf.org/publications/surveillance-hiv-1-pol-transmitted-drug-resistance-acutely-and-recently-infected</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/surveillance-hiv-1-pol-transmitted-drug-resistance-acutely-and-recently-infected" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-sd-bioline-tb-ag-mpt64-test-identification-complex-liquid-cultures</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-sd-bioline-tb-ag-mpt64-test-identification-complex-liquid-cultures" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-deki-readertm-automated-rdt-reader-and-data-management-device-household</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-deki-readertm-automated-rdt-reader-and-data-management-device-household" /></url>
<url><loc>https://epicentre.msf.org/publications/aetiology-and-outcomes-suspected-infections-central-nervous-system-children-mbarara</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/aetiology-and-outcomes-suspected-infections-central-nervous-system-children-mbarara" /></url>
<url><loc>https://epicentre.msf.org/publications/four-years-case-based-surveillance-meningitis-following-introduction-menafrivac</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/four-years-case-based-surveillance-meningitis-following-introduction-menafrivac" /></url>
<url><loc>https://epicentre.msf.org/publications/ensemble-approach-predicting-impact-vaccination-rotavirus-disease-niger</loc><lastmod>2019-02-16T16:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ensemble-approach-predicting-impact-vaccination-rotavirus-disease-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/adapting-global-shortage-cholera-vaccines-targeted-single-dose-cholera-vaccine</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adapting-global-shortage-cholera-vaccines-targeted-single-dose-cholera-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/neighborhood-targeted-and-case-triggered-use-single-dose-oral-cholera-vaccine-urban</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/neighborhood-targeted-and-case-triggered-use-single-dose-oral-cholera-vaccine-urban" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemic-dystonic-reactions-central-africa</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemic-dystonic-reactions-central-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/data-driven-models-foot-and-mouth-disease-dynamics-review</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/data-driven-models-foot-and-mouth-disease-dynamics-review" /></url>
<url><loc>https://epicentre.msf.org/publications/implementation-research-reactive-mass-vaccination-single-dose-oral-cholera-vaccine</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/implementation-research-reactive-mass-vaccination-single-dose-oral-cholera-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/effect-ready-use-foods-preventing-child-undernutrition-niger-analysis-prospective</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effect-ready-use-foods-preventing-child-undernutrition-niger-analysis-prospective" /></url>
<url><loc>https://epicentre.msf.org/publications/health-care-workers-perceptions-point-care-testing-low-income-country-qualitative</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/health-care-workers-perceptions-point-care-testing-low-income-country-qualitative" /></url>
<url><loc>https://epicentre.msf.org/publications/gender-social-and-cultural-influences-management-and-use-unconditional-cash-transfers</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/gender-social-and-cultural-influences-management-and-use-unconditional-cash-transfers" /></url>
<url><loc>https://epicentre.msf.org/publications/alternative-classification-mixture-modeling-longitudinal-counts-or-binary-measures</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/alternative-classification-mixture-modeling-longitudinal-counts-or-binary-measures" /></url>
<url><loc>https://epicentre.msf.org/publications/improved-neonatal-mortality-district-hospital-aweil-south-sudan</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/improved-neonatal-mortality-district-hospital-aweil-south-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/estimating-number-secondary-ebola-cases-resulting-unsafe-burial-and-risk-factors</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimating-number-secondary-ebola-cases-resulting-unsafe-burial-and-risk-factors" /></url>
<url><loc>https://epicentre.msf.org/publications/genomic-history-seventh-pandemic-cholera-africa</loc><lastmod>2019-02-16T16:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/genomic-history-seventh-pandemic-cholera-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/high-resolution-spatial-analysis-cholera-patients-reported-artibonite-department-haiti</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-resolution-spatial-analysis-cholera-patients-reported-artibonite-department-haiti" /></url>
<url><loc>https://epicentre.msf.org/publications/focused-training-humanitarian-responders-regional-anesthesia-techniques-planned</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/focused-training-humanitarian-responders-regional-anesthesia-techniques-planned" /></url>
<url><loc>https://epicentre.msf.org/publications/review-antimicrobial-resistance-east-africa</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/review-antimicrobial-resistance-east-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/xpertr-mtbrif-detection-mycobacterium-tuberculosis-frozen-string-and-induced-sputum</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/xpertr-mtbrif-detection-mycobacterium-tuberculosis-frozen-string-and-induced-sputum" /></url>
<url><loc>https://epicentre.msf.org/publications/population-level-effect-cholera-vaccine-displaced-populations-south-sudan-2014</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/population-level-effect-cholera-vaccine-displaced-populations-south-sudan-2014" /></url>
<url><loc>https://epicentre.msf.org/publications/safe-water-sanitation-hygiene-and-cholera-vaccine</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/safe-water-sanitation-hygiene-and-cholera-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/liberte-egalite-fraternitesante</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/liberte-egalite-fraternitesante" /></url>
<url><loc>https://epicentre.msf.org/publications/pediatric-access-and-continuity-hiv-care-start-antiretroviral-therapy-sub-saharan</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pediatric-access-and-continuity-hiv-care-start-antiretroviral-therapy-sub-saharan" /></url>
<url><loc>https://epicentre.msf.org/publications/potential-impact-multiple-interventions-hiv-incidence-hyperendemic-region-western</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/potential-impact-multiple-interventions-hiv-incidence-hyperendemic-region-western" /></url>
<url><loc>https://epicentre.msf.org/publications/identification-patients-who-could-benefit-bedaquiline-or-delamanid-multisite-mdr-tb</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/identification-patients-who-could-benefit-bedaquiline-or-delamanid-multisite-mdr-tb" /></url>
<url><loc>https://epicentre.msf.org/publications/diagnostic-accuracy-small-membrane-filtration-method-diagnosis-pulmonary-tuberculosis</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/diagnostic-accuracy-small-membrane-filtration-method-diagnosis-pulmonary-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/light-emitting-diode-fluorescence-microscopy-tuberculosis-diagnosis-meta-analysis</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/light-emitting-diode-fluorescence-microscopy-tuberculosis-diagnosis-meta-analysis" /></url>
<url><loc>https://epicentre.msf.org/publications/case-fatality-rates-and-sequelae-resulting-neisseria-meningitidis-serogroup-c-epidemic</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/case-fatality-rates-and-sequelae-resulting-neisseria-meningitidis-serogroup-c-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/timing-malaria-pregnancy-and-impact-infant-growth-and-morbidity-cohort-study-uganda</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/timing-malaria-pregnancy-and-impact-infant-growth-and-morbidity-cohort-study-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/scenario-approach-countries-considering-addition-oral-cholera-vaccination-cholera</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/scenario-approach-countries-considering-addition-oral-cholera-vaccination-cholera" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-artemether-lumefantrine-relation-drug-exposure-children-and-without-severe</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-artemether-lumefantrine-relation-drug-exposure-children-and-without-severe" /></url>
<url><loc>https://epicentre.msf.org/publications/target-product-profile-diagnostic-assay-differentiate-between-bacterial-and-non</loc><lastmod>2019-02-16T16:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/target-product-profile-diagnostic-assay-differentiate-between-bacterial-and-non" /></url>
<url><loc>https://epicentre.msf.org/publications/predictive-modeling-targets-thymidylate-synthase-thyx-mycobacterium-tuberculosis</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/predictive-modeling-targets-thymidylate-synthase-thyx-mycobacterium-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/effect-artesunate-amodiaquine-mortality-related-ebola-virus-disease</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effect-artesunate-amodiaquine-mortality-related-ebola-virus-disease" /></url>
<url><loc>https://epicentre.msf.org/publications/performance-and-time-become-negative-after-treatment-three-malaria-rapid-diagnostic</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/performance-and-time-become-negative-after-treatment-three-malaria-rapid-diagnostic" /></url>
<url><loc>https://epicentre.msf.org/publications/implementation-and-operational-research-feasibility-using-tuberculin-skin-test</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/implementation-and-operational-research-feasibility-using-tuberculin-skin-test" /></url>
<url><loc>https://epicentre.msf.org/publications/who-needs-be-targeted-hiv-testing-and-treatment-kwazulu-natal-results-population-based</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/who-needs-be-targeted-hiv-testing-and-treatment-kwazulu-natal-results-population-based" /></url>
<url><loc>https://epicentre.msf.org/publications/routine-amoxicillin-uncomplicated-severe-acute-malnutrition-children</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/routine-amoxicillin-uncomplicated-severe-acute-malnutrition-children" /></url>
<url><loc>https://epicentre.msf.org/publications/improving-estimates-numbers-children-severe-acute-malnutrition-using-cohort-and-survey</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/improving-estimates-numbers-children-severe-acute-malnutrition-using-cohort-and-survey" /></url>
<url><loc>https://epicentre.msf.org/publications/randomised-phase-ii-trial-evaluate-toxicity-high-dose-rifampicin-treat-pulmonary</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/randomised-phase-ii-trial-evaluate-toxicity-high-dose-rifampicin-treat-pulmonary" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-and-lessons-learned-mass-drug-administrations-malaria-chemoprevention-during</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-and-lessons-learned-mass-drug-administrations-malaria-chemoprevention-during" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-morbidity-and-health-seeking-behaviour-during-ebola-epidemic-2014-2015</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-morbidity-and-health-seeking-behaviour-during-ebola-epidemic-2014-2015" /></url>
<url><loc>https://epicentre.msf.org/publications/community-knowledge-attitudes-and-practices-relation-tuberculosis-cameroon</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/community-knowledge-attitudes-and-practices-relation-tuberculosis-cameroon" /></url>
<url><loc>https://epicentre.msf.org/publications/regional-anesthesia-painful-injuries-after-disasters-rapid-study-protocol-randomized</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/regional-anesthesia-painful-injuries-after-disasters-rapid-study-protocol-randomized" /></url>
<url><loc>https://epicentre.msf.org/publications/development-prediction-model-ebola-virus-disease-retrospective-study-nzerekore-ebola</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/development-prediction-model-ebola-virus-disease-retrospective-study-nzerekore-ebola" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-rates-during-cholera-epidemic-haiti-2010-2011</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-rates-during-cholera-epidemic-haiti-2010-2011" /></url>
<url><loc>https://epicentre.msf.org/publications/detection-and-quantification-mycobacterium-tuberculosis-sputum-culture-negative-hiv</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detection-and-quantification-mycobacterium-tuberculosis-sputum-culture-negative-hiv" /></url>
<url><loc>https://epicentre.msf.org/publications/closer-90-90-90-cascade-care-after-10-years-art-scale-rural-malawi-population-study</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/closer-90-90-90-cascade-care-after-10-years-art-scale-rural-malawi-population-study" /></url>
<url><loc>https://epicentre.msf.org/publications/factors-associated-hiv-status-awareness-and-linkage-care-following-home-based-testing</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/factors-associated-hiv-status-awareness-and-linkage-care-following-home-based-testing" /></url>
<url><loc>https://epicentre.msf.org/publications/maternal-perception-emotional-difficulties-preschool-children-rural-niger</loc><lastmod>2019-02-16T16:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/maternal-perception-emotional-difficulties-preschool-children-rural-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/worldwide-map-plasmodium-falciparum-k13-propeller-polymorphisms</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/worldwide-map-plasmodium-falciparum-k13-propeller-polymorphisms" /></url>
<url><loc>https://epicentre.msf.org/publications/buruli-score-development-multivariable-prediction-model-diagnosis-mycobacterium</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/buruli-score-development-multivariable-prediction-model-diagnosis-mycobacterium" /></url>
<url><loc>https://epicentre.msf.org/publications/invasive-infection-and-outcomes-humanitarian-surgical-burn-program-haiti</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/invasive-infection-and-outcomes-humanitarian-surgical-burn-program-haiti" /></url>
<url><loc>https://epicentre.msf.org/publications/detection-yield-and-tolerability-string-test-diagnosis-childhood-intrathoracic</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detection-yield-and-tolerability-string-test-diagnosis-childhood-intrathoracic" /></url>
<url><loc>https://epicentre.msf.org/publications/global-phylogeography-and-evolutionary-history-shigella-dysenteriae-type-1</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/global-phylogeography-and-evolutionary-history-shigella-dysenteriae-type-1" /></url>
<url><loc>https://epicentre.msf.org/publications/cholera-rapid-test-enrichment-step-has-diagnostic-performance-equivalent-culture</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cholera-rapid-test-enrichment-step-has-diagnostic-performance-equivalent-culture" /></url>
<url><loc>https://epicentre.msf.org/publications/asymptomatic-plasmodium-infections-children-low-malaria-transmission-setting</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/asymptomatic-plasmodium-infections-children-low-malaria-transmission-setting" /></url>
<url><loc>https://epicentre.msf.org/publications/screening-glucose-6-phosphate-dehydrogenase-deficiency-using-three-detection-methods</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/screening-glucose-6-phosphate-dehydrogenase-deficiency-using-three-detection-methods" /></url>
<url><loc>https://epicentre.msf.org/publications/mycobacterium-tuberculosis-lineage-4-comprises-globally-distributed-and-geographically</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mycobacterium-tuberculosis-lineage-4-comprises-globally-distributed-and-geographically" /></url>
<url><loc>https://epicentre.msf.org/publications/encouraging-impact-following-25-years-reinforced-malaria-control-interventions</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/encouraging-impact-following-25-years-reinforced-malaria-control-interventions" /></url>
<url><loc>https://epicentre.msf.org/publications/community-based-surveillance-monitor-mortality-malaria-endemic-and-ebola-epidemic</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/community-based-surveillance-monitor-mortality-malaria-endemic-and-ebola-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/ebola-virus-disease-complications-experienced-survivors-sierra-leone</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ebola-virus-disease-complications-experienced-survivors-sierra-leone" /></url>
<url><loc>https://epicentre.msf.org/publications/eligibility-shorter-multidrug-resistant-tuberculosis-regimen-ambiguities-world-health</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/eligibility-shorter-multidrug-resistant-tuberculosis-regimen-ambiguities-world-health" /></url>
<url><loc>https://epicentre.msf.org/publications/changes-health-seeking-behavior-did-not-result-increased-all-cause-mortality-during</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/changes-health-seeking-behavior-did-not-result-increased-all-cause-mortality-during" /></url>
<url><loc>https://epicentre.msf.org/publications/gametocyte-carriage-uncomplicated-plasmodium-falciparum-malaria-following-treatment</loc><lastmod>2019-02-16T16:45Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/gametocyte-carriage-uncomplicated-plasmodium-falciparum-malaria-following-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/first-use-global-oral-cholera-vaccine-emergency-stockpile-lessons-south-sudan</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/first-use-global-oral-cholera-vaccine-emergency-stockpile-lessons-south-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/thin-layer-agar-method-direct-phenotypic-detection-multi-and-extensively-drug</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/thin-layer-agar-method-direct-phenotypic-detection-multi-and-extensively-drug" /></url>
<url><loc>https://epicentre.msf.org/publications/intra-gastric-string-test-effective-tool-diagnosing-tuberculosis-adults-unable-produce</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/intra-gastric-string-test-effective-tool-diagnosing-tuberculosis-adults-unable-produce" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-one-dose-versus-two-dose-oral-cholera-vaccine-regimen-outbreak-settings</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-one-dose-versus-two-dose-oral-cholera-vaccine-regimen-outbreak-settings" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreaks-cholera-time-ebola-pre-emptive-action-needed</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreaks-cholera-time-ebola-pre-emptive-action-needed" /></url>
<url><loc>https://epicentre.msf.org/publications/long-term-efficacy-hepatitis-e-vaccine</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/long-term-efficacy-hepatitis-e-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/effects-treatment-interruption-patterns-treatment-success-among-patients-multidrug</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effects-treatment-interruption-patterns-treatment-success-among-patients-multidrug" /></url>
<url><loc>https://epicentre.msf.org/publications/reply-how-do-new-definitions-multidrug-resistant-tuberculosis-treatment-outcomes</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reply-how-do-new-definitions-multidrug-resistant-tuberculosis-treatment-outcomes" /></url>
<url><loc>https://epicentre.msf.org/publications/revised-definitions-multidrug-resistant-tuberculosis-treatment-outcomes-closer-reality</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/revised-definitions-multidrug-resistant-tuberculosis-treatment-outcomes-closer-reality" /></url>
<url><loc>https://epicentre.msf.org/publications/nevirapine-or-efavirenz-tuberculosis-and-hiv-coinfected-patients-exposure-and</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nevirapine-or-efavirenz-tuberculosis-and-hiv-coinfected-patients-exposure-and" /></url>
<url><loc>https://epicentre.msf.org/publications/estimation-and-short-term-prediction-course-hiv-epidemic-using-demographic-and-health</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimation-and-short-term-prediction-course-hiv-epidemic-using-demographic-and-health" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-variability-adherence-hiv-antiretroviral-therapy-immunovirological-response-and</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-variability-adherence-hiv-antiretroviral-therapy-immunovirological-response-and" /></url>
<url><loc>https://epicentre.msf.org/publications/association-between-hrp-2pldh-rapid-diagnostic-test-band-positivity-and-malaria</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/association-between-hrp-2pldh-rapid-diagnostic-test-band-positivity-and-malaria" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemiology-hbv-infection-cohort-ugandan-hiv-infected-patients-and-rate-and-pattern</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemiology-hbv-infection-cohort-ugandan-hiv-infected-patients-and-rate-and-pattern" /></url>
<url><loc>https://epicentre.msf.org/publications/temporal-changes-ebola-transmission-sierra-leone-and-implications-control-requirements</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/temporal-changes-ebola-transmission-sierra-leone-and-implications-control-requirements" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-pcr-detection-cambodian-low-transmission-settings-dried-blood-spots-versus</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-pcr-detection-cambodian-low-transmission-settings-dried-blood-spots-versus" /></url>
<url><loc>https://epicentre.msf.org/publications/prevention-acute-malnutrition-distribution-special-nutritious-foods-and-cash-and</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevention-acute-malnutrition-distribution-special-nutritious-foods-and-cash-and" /></url>
<url><loc>https://epicentre.msf.org/publications/multi-center-open-label-trial-compare-efficacy-and-pharmacokinetics-artemether</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/multi-center-open-label-trial-compare-efficacy-and-pharmacokinetics-artemether" /></url>
<url><loc>https://epicentre.msf.org/publications/errors-generated-point-care-cd4-t-lymphocyte-analyser-retrospective-observational</loc><lastmod>2019-02-16T16:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/errors-generated-point-care-cd4-t-lymphocyte-analyser-retrospective-observational" /></url>
<url><loc>https://epicentre.msf.org/publications/use-capture-recapture-estimate-underreporting-ebola-virus-disease-montserrado-county</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/use-capture-recapture-estimate-underreporting-ebola-virus-disease-montserrado-county" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-weight-height-and-mid-upper-arm-circumference-muac-therapeutic-feeding</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-weight-height-and-mid-upper-arm-circumference-muac-therapeutic-feeding" /></url>
<url><loc>https://epicentre.msf.org/publications/pregnancy-outcomes-after-mass-vaccination-campaign-oral-cholera-vaccine-guinea</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pregnancy-outcomes-after-mass-vaccination-campaign-oral-cholera-vaccine-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-and-effectiveness-rvsv-vectored-vaccine-expressing-ebola-surface-glycoprotein</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-and-effectiveness-rvsv-vectored-vaccine-expressing-ebola-surface-glycoprotein" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-clinical-characteristics-and-treatment-outcomes-children-selected-treatment</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-clinical-characteristics-and-treatment-outcomes-children-selected-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/multidistrict-outbreak-marburg-virus-disease-uganda-2012</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/multidistrict-outbreak-marburg-virus-disease-uganda-2012" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-benefits-and-risks-introducing-ebola-community-care-centers-sierra-leone</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-benefits-and-risks-introducing-ebola-community-care-centers-sierra-leone" /></url>
<url><loc>https://epicentre.msf.org/publications/enteric-bacterial-pathogens-children-diarrhea-niger-diversity-and-antimicrobial</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/enteric-bacterial-pathogens-children-diarrhea-niger-diversity-and-antimicrobial" /></url>
<url><loc>https://epicentre.msf.org/publications/vaccine-testing-ebola-and-beyond</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vaccine-testing-ebola-and-beyond" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-oral-cholera-vaccine-haiti</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-oral-cholera-vaccine-haiti" /></url>
<url><loc>https://epicentre.msf.org/publications/cascade-hiv-care-and-population-viral-suppression-high-burden-region-kenya</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cascade-hiv-care-and-population-viral-suppression-high-burden-region-kenya" /></url>
<url><loc>https://epicentre.msf.org/publications/screening-psychological-difficulties-young-children-crisis-complementary-cross</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/screening-psychological-difficulties-young-children-crisis-complementary-cross" /></url>
<url><loc>https://epicentre.msf.org/publications/evolutionary-history-and-global-spread-mycobacterium-tuberculosis-beijing-lineage</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evolutionary-history-and-global-spread-mycobacterium-tuberculosis-beijing-lineage" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-and-genotypic-characterization-extended-spectrum-beta-lactamases-produced</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-and-genotypic-characterization-extended-spectrum-beta-lactamases-produced" /></url>
<url><loc>https://epicentre.msf.org/publications/inhaled-nitric-oxide-adjunctive-treatment-cerebral-malaria-children-phase-ii</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/inhaled-nitric-oxide-adjunctive-treatment-cerebral-malaria-children-phase-ii" /></url>
<url><loc>https://epicentre.msf.org/publications/determinants-visceral-leishmaniasis-case-control-study-gedaref-state-sudan</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/determinants-visceral-leishmaniasis-case-control-study-gedaref-state-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/early-biting-and-insecticide-resistance-malaria-vector-anopheles-might-compromise</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/early-biting-and-insecticide-resistance-malaria-vector-anopheles-might-compromise" /></url>
<url><loc>https://epicentre.msf.org/publications/low-resistance-first-and-second-line-anti-tuberculosis-drugs-among-treatment-naive</loc><lastmod>2019-02-16T16:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/low-resistance-first-and-second-line-anti-tuberculosis-drugs-among-treatment-naive" /></url>
<url><loc>https://epicentre.msf.org/publications/geographic-distribution-and-mortality-risk-factors-during-cholera-outbreak-rural</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/geographic-distribution-and-mortality-risk-factors-during-cholera-outbreak-rural" /></url>
<url><loc>https://epicentre.msf.org/publications/routine-use-xpertr-mtbrif-areas-different-prevalences-hiv-and-drug-resistant</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/routine-use-xpertr-mtbrif-areas-different-prevalences-hiv-and-drug-resistant" /></url>
<url><loc>https://epicentre.msf.org/publications/sustainable-hiv-treatment-africa-through-viral-load-informed-differentiated-care</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sustainable-hiv-treatment-africa-through-viral-load-informed-differentiated-care" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-and-mortality-associated-resistance-first-line-antiretroviral-therapy</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-and-mortality-associated-resistance-first-line-antiretroviral-therapy" /></url>
<url><loc>https://epicentre.msf.org/publications/detection-drug-resistant-tuberculosis-xpert-mtbrif-swaziland</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detection-drug-resistant-tuberculosis-xpert-mtbrif-swaziland" /></url>
<url><loc>https://epicentre.msf.org/publications/preventive-effects-long-term-supplementation-2-nutritious-food-supplements-young</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/preventive-effects-long-term-supplementation-2-nutritious-food-supplements-young" /></url>
<url><loc>https://epicentre.msf.org/publications/sociocultural-and-structural-factors-contributing-delays-treatment-children-severe</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sociocultural-and-structural-factors-contributing-delays-treatment-children-severe" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-hiv-related-thrombocytopenia-among-clients-mbarara-regional-referral</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-hiv-related-thrombocytopenia-among-clients-mbarara-regional-referral" /></url>
<url><loc>https://epicentre.msf.org/publications/effect-dosing-strategies-therapeutic-efficacy-artesunate-amodiaquine-uncomplicated</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effect-dosing-strategies-therapeutic-efficacy-artesunate-amodiaquine-uncomplicated" /></url>
<url><loc>https://epicentre.msf.org/publications/surgical-care-pediatric-patients-humanitarian-setting-medecins-sans-frontieres</loc><lastmod>2019-02-16T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/surgical-care-pediatric-patients-humanitarian-setting-medecins-sans-frontieres" /></url>
<url><loc>https://epicentre.msf.org/publications/using-bd-vacutainer-cd4-stabilization-tubes-absolute-cluster-differentiation-type-4</loc><lastmod>2019-02-16T17:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/using-bd-vacutainer-cd4-stabilization-tubes-absolute-cluster-differentiation-type-4" /></url>
<url><loc>https://epicentre.msf.org/publications/drug-resistant-tuberculosis-hiv-infected-patients-national-referral-hospital-phnom</loc><lastmod>2019-02-16T17:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/drug-resistant-tuberculosis-hiv-infected-patients-national-referral-hospital-phnom" /></url>
<url><loc>https://epicentre.msf.org/publications/emergence-zaire-ebola-virus-disease-guinea</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/emergence-zaire-ebola-virus-disease-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/polio-eradication-campaign-time-shift-goal</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/polio-eradication-campaign-time-shift-goal" /></url>
<url><loc>https://epicentre.msf.org/publications/long-term-adherence-haart-senegal</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/long-term-adherence-haart-senegal" /></url>
<url><loc>https://epicentre.msf.org/publications/pharmacokinetics-rifampin-and-isoniazid-tuberculosis-hiv-coinfected-patients-receiving</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pharmacokinetics-rifampin-and-isoniazid-tuberculosis-hiv-coinfected-patients-receiving" /></url>
<url><loc>https://epicentre.msf.org/publications/plasmodium-prevalence-and-artemisinin-resistant-falciparum-malaria-preah-vihear</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/plasmodium-prevalence-and-artemisinin-resistant-falciparum-malaria-preah-vihear" /></url>
<url><loc>https://epicentre.msf.org/publications/male-gender-independently-associated-pulmonary-tuberculosis-among-sputum-and-non</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/male-gender-independently-associated-pulmonary-tuberculosis-among-sputum-and-non" /></url>
<url><loc>https://epicentre.msf.org/publications/modeling-seasonality-anopheles-gambiae-ss-biting-rates-south-benin-sanitary-zone</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/modeling-seasonality-anopheles-gambiae-ss-biting-rates-south-benin-sanitary-zone" /></url>
<url><loc>https://epicentre.msf.org/publications/time-still-essence-quantifying-impact-emergency-meningitis-vaccination-response</loc><lastmod>2019-02-17T08:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/time-still-essence-quantifying-impact-emergency-meningitis-vaccination-response" /></url>
<url><loc>https://epicentre.msf.org/publications/vaccination-humanitarian-crises-satisficing-should-no-longer-suffice</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vaccination-humanitarian-crises-satisficing-should-no-longer-suffice" /></url>
<url><loc>https://epicentre.msf.org/publications/keeping-rotavirus-vaccines-international-agenda</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/keeping-rotavirus-vaccines-international-agenda" /></url>
<url><loc>https://epicentre.msf.org/publications/outcomes-antiretroviral-therapy-over-10-year-period-expansion-multicohort-analysis</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outcomes-antiretroviral-therapy-over-10-year-period-expansion-multicohort-analysis" /></url>
<url><loc>https://epicentre.msf.org/publications/local-discrepancies-measles-vaccination-opportunities-results-population-based-surveys</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/local-discrepancies-measles-vaccination-opportunities-results-population-based-surveys" /></url>
<url><loc>https://epicentre.msf.org/publications/cluster-randomized-non-inferiority-field-trial-immunogenicity-and-safety-tetanus</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cluster-randomized-non-inferiority-field-trial-immunogenicity-and-safety-tetanus" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-bordetella-infection-hospital-setting-niamey-niger</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-bordetella-infection-hospital-setting-niamey-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/lowenstein-jensen-selective-medium-reducing-contamination-mycobacterium-tuberculosis</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/lowenstein-jensen-selective-medium-reducing-contamination-mycobacterium-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-modified-colorimetric-resazurin-microtiter-plate-based-antibacterial-assay</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-modified-colorimetric-resazurin-microtiter-plate-based-antibacterial-assay" /></url>
<url><loc>https://epicentre.msf.org/publications/preventing-acute-malnutrition-among-young-children-crises-prospective-intervention</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/preventing-acute-malnutrition-among-young-children-crises-prospective-intervention" /></url>
<url><loc>https://epicentre.msf.org/publications/mental-disorders-disability-and-treatment-gap-protracted-refugee-setting</loc><lastmod>2019-02-17T08:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mental-disorders-disability-and-treatment-gap-protracted-refugee-setting" /></url>
<url><loc>https://epicentre.msf.org/publications/use-vibrio-cholerae-vaccine-outbreak-guinea</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/use-vibrio-cholerae-vaccine-outbreak-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/physiotherapy-poliomyelitis-descriptive-study-republic-congo</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/physiotherapy-poliomyelitis-descriptive-study-republic-congo" /></url>
<url><loc>https://epicentre.msf.org/publications/description-large-measles-epidemic-democratic-republic-congo-2010-2013</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/description-large-measles-epidemic-democratic-republic-congo-2010-2013" /></url>
<url><loc>https://epicentre.msf.org/publications/clinical-epidemiology-diagnosis-and-treatment-visceral-leishmaniasis-pokot-endemic</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/clinical-epidemiology-diagnosis-and-treatment-visceral-leishmaniasis-pokot-endemic" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-sd-bioline-hivsyphilis-duo-assay-rural-health-center-southwestern-uganda</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-sd-bioline-hivsyphilis-duo-assay-rural-health-center-southwestern-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/diagnostic-and-prognostic-value-procalcitonin-and-c-reactive-protein-malnourished</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/diagnostic-and-prognostic-value-procalcitonin-and-c-reactive-protein-malnourished" /></url>
<url><loc>https://epicentre.msf.org/publications/rotavirus-surveillance-urban-and-rural-areas-niger-april-2010-march-2012</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/rotavirus-surveillance-urban-and-rural-areas-niger-april-2010-march-2012" /></url>
<url><loc>https://epicentre.msf.org/publications/descriptive-epidemiology-typhoid-fever-during-epidemic-harare-zimbabwe-2012</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/descriptive-epidemiology-typhoid-fever-during-epidemic-harare-zimbabwe-2012" /></url>
<url><loc>https://epicentre.msf.org/publications/emerging-filoviral-disease-uganda-proposed-explanations-and-research-directions</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/emerging-filoviral-disease-uganda-proposed-explanations-and-research-directions" /></url>
<url><loc>https://epicentre.msf.org/publications/factor-structure-and-presentation-depression-among-hiv-positive-adults-uganda</loc><lastmod>2019-02-17T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/factor-structure-and-presentation-depression-among-hiv-positive-adults-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/reasons-defaulting-drug-resistant-tuberculosis-treatment-armenia-quantitative-and</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reasons-defaulting-drug-resistant-tuberculosis-treatment-armenia-quantitative-and" /></url>
<url><loc>https://epicentre.msf.org/publications/quality-assessment-x-rays-interpreted-teleradiology-medecins-sans-frontieres</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/quality-assessment-x-rays-interpreted-teleradiology-medecins-sans-frontieres" /></url>
<url><loc>https://epicentre.msf.org/publications/post-licensure-deployment-oral-cholera-vaccines-systematic-review</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/post-licensure-deployment-oral-cholera-vaccines-systematic-review" /></url>
<url><loc>https://epicentre.msf.org/publications/short-musculoskeletal-functional-assessment-smfa-score-amongst-surgical-patients</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/short-musculoskeletal-functional-assessment-smfa-score-amongst-surgical-patients" /></url>
<url><loc>https://epicentre.msf.org/publications/medecins-sans-frontieres-experience-orthopedic-surgery-postearthquake-haiti-2010</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/medecins-sans-frontieres-experience-orthopedic-surgery-postearthquake-haiti-2010" /></url>
<url><loc>https://epicentre.msf.org/publications/antimicrobial-drug-resistant-bacteria-isolated-syrian-war-injured-patients-august-2011</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antimicrobial-drug-resistant-bacteria-isolated-syrian-war-injured-patients-august-2011" /></url>
<url><loc>https://epicentre.msf.org/publications/cd4-cell-count-antiretroviral-therapy-initiation-and-economic-restoration-rural-uganda</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cd4-cell-count-antiretroviral-therapy-initiation-and-economic-restoration-rural-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/introducing-rapid-culture-diagnostic-algorithm-smear-negative-tuberculosis-cost</loc><lastmod>2019-02-17T08:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/introducing-rapid-culture-diagnostic-algorithm-smear-negative-tuberculosis-cost" /></url>
<url><loc>https://epicentre.msf.org/publications/priorities-research-meningococcal-disease-and-impact-serogroup-vaccination-african</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/priorities-research-meningococcal-disease-and-impact-serogroup-vaccination-african" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-uncommon-cause-adult-sepsis-south-western-uganda</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-uncommon-cause-adult-sepsis-south-western-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/adults-receiving-hiv-care-start-antiretroviral-therapy-sub-saharan-africa-patient</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adults-receiving-hiv-care-start-antiretroviral-therapy-sub-saharan-africa-patient" /></url>
<url><loc>https://epicentre.msf.org/publications/women-experience-better-long-term-immune-recovery-and-better-survival-haart-lao</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/women-experience-better-long-term-immune-recovery-and-better-survival-haart-lao" /></url>
<url><loc>https://epicentre.msf.org/publications/description-and-predictive-factors-individual-outcomes-refugee-camp-based-mental</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/description-and-predictive-factors-individual-outcomes-refugee-camp-based-mental" /></url>
<url><loc>https://epicentre.msf.org/publications/paediatric-hiv-care-sub-saharan-africa-clinical-presentation-and-2-year-outcomes</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/paediatric-hiv-care-sub-saharan-africa-clinical-presentation-and-2-year-outcomes" /></url>
<url><loc>https://epicentre.msf.org/publications/incidence-paradoxical-tuberculosis-associated-immune-reconstitution-inflammatory</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/incidence-paradoxical-tuberculosis-associated-immune-reconstitution-inflammatory" /></url>
<url><loc>https://epicentre.msf.org/publications/nevirapine-versus-efavirenz-patients-co-infected-hiv-and-tuberculosis-randomised-non</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nevirapine-versus-efavirenz-patients-co-infected-hiv-and-tuberculosis-randomised-non" /></url>
<url><loc>https://epicentre.msf.org/publications/use-colorimetric-culture-methods-detection-mycobacterium-tuberculosis-complex-isolates</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/use-colorimetric-culture-methods-detection-mycobacterium-tuberculosis-complex-isolates" /></url>
<url><loc>https://epicentre.msf.org/publications/cholera-pregnancy-outcomes-specialized-cholera-treatment-unit-pregnant-women-leogane</loc><lastmod>2019-02-17T08:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cholera-pregnancy-outcomes-specialized-cholera-treatment-unit-pregnant-women-leogane" /></url>
<url><loc>https://epicentre.msf.org/publications/feasibility-mass-vaccination-campaign-oral-cholera-vaccines-response-outbreak-guinea</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/feasibility-mass-vaccination-campaign-oral-cholera-vaccines-response-outbreak-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/brief-mental-health-interventions-conflict-and-emergency-settings-overview-four</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/brief-mental-health-interventions-conflict-and-emergency-settings-overview-four" /></url>
<url><loc>https://epicentre.msf.org/publications/effect-serogroup-meningococcal-conjugate-vaccine-psa-tt-serogroup-meningococcal</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effect-serogroup-meningococcal-conjugate-vaccine-psa-tt-serogroup-meningococcal" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-malaria-during-pregnancy-pregnancy-outcomes-ugandan-prospective-cohort</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-malaria-during-pregnancy-pregnancy-outcomes-ugandan-prospective-cohort" /></url>
<url><loc>https://epicentre.msf.org/publications/development-cross-over-randomized-trial-method-determine-acceptability-and-safety</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/development-cross-over-randomized-trial-method-determine-acceptability-and-safety" /></url>
<url><loc>https://epicentre.msf.org/publications/graphical-method-assess-distribution-assumption-group-based-trajectory-models</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/graphical-method-assess-distribution-assumption-group-based-trajectory-models" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-aids-morbidity-and-loss-follow-current-cd4-cell-count-among-hiv-1-infected</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-aids-morbidity-and-loss-follow-current-cd4-cell-count-among-hiv-1-infected" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-cholera-transmission-haiti-during-inter-peak-periods-insights-improve</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-cholera-transmission-haiti-during-inter-peak-periods-insights-improve" /></url>
<url><loc>https://epicentre.msf.org/publications/observational-bias-during-nutrition-surveillance-results-mixed-longitudinal-and-cross</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/observational-bias-during-nutrition-surveillance-results-mixed-longitudinal-and-cross" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-democratic-republic-congo-outbreak-description-katanga-2010-2011</loc><lastmod>2019-02-17T08:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-democratic-republic-congo-outbreak-description-katanga-2010-2011" /></url>
<url><loc>https://epicentre.msf.org/publications/high-maternal-and-neonatal-mortality-rates-northern-nigeria-8-month-observational</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-maternal-and-neonatal-mortality-rates-northern-nigeria-8-month-observational" /></url>
<url><loc>https://epicentre.msf.org/publications/factors-associated-severe-preeclampsia-and-eclampsia-jahun-nigeria</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/factors-associated-severe-preeclampsia-and-eclampsia-jahun-nigeria" /></url>
<url><loc>https://epicentre.msf.org/publications/first-outbreak-response-using-oral-cholera-vaccine-africa-vaccine-coverage</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/first-outbreak-response-using-oral-cholera-vaccine-africa-vaccine-coverage" /></url>
<url><loc>https://epicentre.msf.org/publications/use-cholera-rapid-diagnostic-test-during-mass-vaccination-campaign-response-epidemic</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/use-cholera-rapid-diagnostic-test-during-mass-vaccination-campaign-response-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/task-sharing-hiv-care-and-art-initiation-evaluation-mixed-care-non-physician-provider</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/task-sharing-hiv-care-and-art-initiation-evaluation-mixed-care-non-physician-provider" /></url>
<url><loc>https://epicentre.msf.org/publications/lessons-and-challenges-measles-control-unexpected-large-outbreak-malawi</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/lessons-and-challenges-measles-control-unexpected-large-outbreak-malawi" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-outbreak-response-immunization-context-specific-insight-recent-experience</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-outbreak-response-immunization-context-specific-insight-recent-experience" /></url>
<url><loc>https://epicentre.msf.org/publications/reaching-hard-reach-individuals-nonselective-versus-targeted-outbreak-response</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reaching-hard-reach-individuals-nonselective-versus-targeted-outbreak-response" /></url>
<url><loc>https://epicentre.msf.org/publications/community-based-measles-mortality-surveillance-two-districts-katanga-province</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/community-based-measles-mortality-surveillance-two-districts-katanga-province" /></url>
<url><loc>https://epicentre.msf.org/publications/infections-children-admitted-complicated-severe-acute-malnutrition-niger</loc><lastmod>2019-02-17T08:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/infections-children-admitted-complicated-severe-acute-malnutrition-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/public-health-surveillance-after-2010-haiti-earthquake-experience-medecins-sans</loc><lastmod>2019-02-17T08:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/public-health-surveillance-after-2010-haiti-earthquake-experience-medecins-sans" /></url>
<url><loc>https://epicentre.msf.org/publications/high-levels-mortality-malnutrition-and-measles-among-recently-displaced-somali</loc><lastmod>2019-02-17T08:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-levels-mortality-malnutrition-and-measles-among-recently-displaced-somali" /></url>
<url><loc>https://epicentre.msf.org/publications/multidrug-and-isoniazid-resistant-tuberculosis-three-high-hiv-burden-african-regions</loc><lastmod>2019-02-17T08:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/multidrug-and-isoniazid-resistant-tuberculosis-three-high-hiv-burden-african-regions" /></url>
<url><loc>https://epicentre.msf.org/publications/tolerability-and-safety-artesunate-amodiaquine-and-artemether-lumefantrine-fixed-dose</loc><lastmod>2019-02-17T08:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/tolerability-and-safety-artesunate-amodiaquine-and-artemether-lumefantrine-fixed-dose" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-artesunate-amodiaquine-and-artemether-lumefantrine-fixed-dose-combinations</loc><lastmod>2019-02-17T08:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-artesunate-amodiaquine-and-artemether-lumefantrine-fixed-dose-combinations" /></url>
<url><loc>https://epicentre.msf.org/publications/value-and-challenges-cholera-vaccines-africa</loc><lastmod>2019-02-17T08:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/value-and-challenges-cholera-vaccines-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/urban-cholera-transmission-hotspots-and-their-implications-reactive-vaccination</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/urban-cholera-transmission-hotspots-and-their-implications-reactive-vaccination" /></url>
<url><loc>https://epicentre.msf.org/publications/mechanistic-and-structural-basis-inhibition-thymidylate-synthase-thyx</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mechanistic-and-structural-basis-inhibition-thymidylate-synthase-thyx" /></url>
<url><loc>https://epicentre.msf.org/publications/timeliness-clinic-attendance-good-predictor-virological-response-and-resistance</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/timeliness-clinic-attendance-good-predictor-virological-response-and-resistance" /></url>
<url><loc>https://epicentre.msf.org/publications/inhaled-nitric-oxide-and-cerebral-malaria-basis-strategy-buying-time-pharmacotherapy</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/inhaled-nitric-oxide-and-cerebral-malaria-basis-strategy-buying-time-pharmacotherapy" /></url>
<url><loc>https://epicentre.msf.org/publications/spatial-dynamics-meningococcal-meningitis-niger-observed-patterns-comparison-measles</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/spatial-dynamics-meningococcal-meningitis-niger-observed-patterns-comparison-measles" /></url>
<url><loc>https://epicentre.msf.org/publications/sentinel-site-community-surveillance-mortality-and-nutritional-status-southwestern</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sentinel-site-community-surveillance-mortality-and-nutritional-status-southwestern" /></url>
<url><loc>https://epicentre.msf.org/publications/intra-household-use-and-acceptability-ready-use-supplementary-foods-distributed-niger</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/intra-household-use-and-acceptability-ready-use-supplementary-foods-distributed-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/performance-histidine-rich-protein-2-rapid-diagnostic-test-paracheck-pfr-detection</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/performance-histidine-rich-protein-2-rapid-diagnostic-test-paracheck-pfr-detection" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-fixed-dose-combination-artesunate-amodiaquine-versus-artemether-lumefantrine</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-fixed-dose-combination-artesunate-amodiaquine-versus-artemether-lumefantrine" /></url>
<url><loc>https://epicentre.msf.org/publications/reconstruction-nonunion-tibial-fractures-war-wounded-iraqi-civilians-2006-2008-better</loc><lastmod>2019-02-17T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reconstruction-nonunion-tibial-fractures-war-wounded-iraqi-civilians-2006-2008-better" /></url>
<url><loc>https://epicentre.msf.org/publications/effect-mass-supplementation-ready-use-supplementary-food-during-anticipated</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effect-mass-supplementation-ready-use-supplementary-food-during-anticipated" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-and-use-surveillance-system-data-toward-identification-high-risk-areas</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-and-use-surveillance-system-data-toward-identification-high-risk-areas" /></url>
<url><loc>https://epicentre.msf.org/publications/reconstruction-residual-mandibular-defects-iliac-crest-bone-graft-war-wounded-iraqi</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reconstruction-residual-mandibular-defects-iliac-crest-bone-graft-war-wounded-iraqi" /></url>
<url><loc>https://epicentre.msf.org/publications/diagnosing-severe-falciparum-malaria-parasitaemic-african-children-prospective</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/diagnosing-severe-falciparum-malaria-parasitaemic-african-children-prospective" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-methods-correct-survival-estimates-and-survival-regression-analysis-large</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-methods-correct-survival-estimates-and-survival-regression-analysis-large" /></url>
<url><loc>https://epicentre.msf.org/publications/performance-2007-who-algorithm-diagnose-smear-negative-pulmonary-tuberculosis-hiv</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/performance-2007-who-algorithm-diagnose-smear-negative-pulmonary-tuberculosis-hiv" /></url>
<url><loc>https://epicentre.msf.org/publications/bridging-gap-knowledge-delivery-control-childhood-diarrhoea</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/bridging-gap-knowledge-delivery-control-childhood-diarrhoea" /></url>
<url><loc>https://epicentre.msf.org/publications/short-and-longer-term-psychological-consequences-operation-cast-lead-documentation</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/short-and-longer-term-psychological-consequences-operation-cast-lead-documentation" /></url>
<url><loc>https://epicentre.msf.org/publications/gender-differences-immune-reconstitution-multicentric-cohort-analysis-sub-saharan</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/gender-differences-immune-reconstitution-multicentric-cohort-analysis-sub-saharan" /></url>
<url><loc>https://epicentre.msf.org/publications/response-antiretroviral-therapy-improved-survival-associated-cd4-above-500-cellsml</loc><lastmod>2019-02-17T08:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/response-antiretroviral-therapy-improved-survival-associated-cd4-above-500-cellsml" /></url>
<url><loc>https://epicentre.msf.org/publications/very-early-anthropometric-changes-after-antiretroviral-therapy-predict-subsequent</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/very-early-anthropometric-changes-after-antiretroviral-therapy-predict-subsequent" /></url>
<url><loc>https://epicentre.msf.org/publications/rapid-screening-tool-psychological-distress-children-3-6years-old-results-validation</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/rapid-screening-tool-psychological-distress-children-3-6years-old-results-validation" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-initiation-program-attrition-and-patient-treatment-outcomes-associated-scale</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-initiation-program-attrition-and-patient-treatment-outcomes-associated-scale" /></url>
<url><loc>https://epicentre.msf.org/publications/performance-small-cluster-surveys-and-clustered-lqas-design-estimate-local-level</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/performance-small-cluster-surveys-and-clustered-lqas-design-estimate-local-level" /></url>
<url><loc>https://epicentre.msf.org/publications/artemether-lumefantrine-treat-malaria-pregnancy-associated-reduced-placental-haemozoin</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/artemether-lumefantrine-treat-malaria-pregnancy-associated-reduced-placental-haemozoin" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-blood-transfusions-and-risk-factors-mortality-children-aged-1-month-4</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-blood-transfusions-and-risk-factors-mortality-children-aged-1-month-4" /></url>
<url><loc>https://epicentre.msf.org/publications/burden-visceral-leishmaniasis-villages-eastern-gedaref-state-sudan-exhaustive-cross</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/burden-visceral-leishmaniasis-villages-eastern-gedaref-state-sudan-exhaustive-cross" /></url>
<url><loc>https://epicentre.msf.org/publications/adherence-self-administered-tuberculosis-treatment-high-hiv-prevalence-setting-cross</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adherence-self-administered-tuberculosis-treatment-high-hiv-prevalence-setting-cross" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-rapid-test-diagnosis-cholera-absence-gold-standard</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-rapid-test-diagnosis-cholera-absence-gold-standard" /></url>
<url><loc>https://epicentre.msf.org/publications/early-prediction-treatment-efficacy-second-stage-gambiense-human-african</loc><lastmod>2019-02-17T08:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/early-prediction-treatment-efficacy-second-stage-gambiense-human-african" /></url>
<url><loc>https://epicentre.msf.org/publications/sequence-variation-does-not-confound-measurement-plasma-pfhrp2-concentration-african</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sequence-variation-does-not-confound-measurement-plasma-pfhrp2-concentration-african" /></url>
<url><loc>https://epicentre.msf.org/publications/high-prevalence-multidrug-resistant-tuberculosis-swaziland-2009-2010</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-prevalence-multidrug-resistant-tuberculosis-swaziland-2009-2010" /></url>
<url><loc>https://epicentre.msf.org/publications/thinking-outside-hospital-effective-paediatric-care-medecins-sans-frontieres-viewpoint</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/thinking-outside-hospital-effective-paediatric-care-medecins-sans-frontieres-viewpoint" /></url>
<url><loc>https://epicentre.msf.org/publications/field-evaluation-simple-fluorescence-method-detection-viable-mycobacterium</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/field-evaluation-simple-fluorescence-method-detection-viable-mycobacterium" /></url>
<url><loc>https://epicentre.msf.org/publications/incidence-risk-factors-and-causes-death-hiv-care-programme-large-proportion-injecting</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/incidence-risk-factors-and-causes-death-hiv-care-programme-large-proportion-injecting" /></url>
<url><loc>https://epicentre.msf.org/publications/population-pharmacokinetics-artemether-and-dihydroartemisinin-pregnant-women</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/population-pharmacokinetics-artemether-and-dihydroartemisinin-pregnant-women" /></url>
<url><loc>https://epicentre.msf.org/publications/glucose-6-phosphate-dehydrogenase-deficiency-chlorproguanil-dapsone-artesunate-and</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/glucose-6-phosphate-dehydrogenase-deficiency-chlorproguanil-dapsone-artesunate-and" /></url>
<url><loc>https://epicentre.msf.org/publications/predicting-clinical-outcome-severe-falciparum-malaria-african-children-findings-large</loc><lastmod>2019-02-17T08:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/predicting-clinical-outcome-severe-falciparum-malaria-african-children-findings-large" /></url>
<url><loc>https://epicentre.msf.org/publications/nutrition-outcomes-hiv-infected-malnourished-adults-treated-ready-use-therapeutic-food</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nutrition-outcomes-hiv-infected-malnourished-adults-treated-ready-use-therapeutic-food" /></url>
<url><loc>https://epicentre.msf.org/publications/immunovirological-response-combined-antiretroviral-therapy-and-drug-resistance</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/immunovirological-response-combined-antiretroviral-therapy-and-drug-resistance" /></url>
<url><loc>https://epicentre.msf.org/publications/avidity-serogroup-meningococcal-igg-antibodies-after-immunization-different-doses</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/avidity-serogroup-meningococcal-igg-antibodies-after-immunization-different-doses" /></url>
<url><loc>https://epicentre.msf.org/publications/revisiting-long-term-adherence-highly-active-antiretroviral-therapy-senegal-using</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/revisiting-long-term-adherence-highly-active-antiretroviral-therapy-senegal-using" /></url>
<url><loc>https://epicentre.msf.org/publications/explaining-seasonal-fluctuations-measles-niger-using-nighttime-lights-imagery</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/explaining-seasonal-fluctuations-measles-niger-using-nighttime-lights-imagery" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-combined-led-fluorescence-microscopy-and-bleach-sedimentation-diagnosis</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-combined-led-fluorescence-microscopy-and-bleach-sedimentation-diagnosis" /></url>
<url><loc>https://epicentre.msf.org/publications/performance-led-based-fluorescence-microscopy-diagnose-tuberculosis-peripheral-health</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/performance-led-based-fluorescence-microscopy-diagnose-tuberculosis-peripheral-health" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-tuberculosis-region-high-drug-resistance-outcomes-drug-resistance</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-tuberculosis-region-high-drug-resistance-outcomes-drug-resistance" /></url>
<url><loc>https://epicentre.msf.org/publications/should-outbreak-response-immunization-be-recommended-measles-outbreaks-middle-and-low</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/should-outbreak-response-immunization-be-recommended-measles-outbreaks-middle-and-low" /></url>
<url><loc>https://epicentre.msf.org/publications/high-mortality-among-older-patients-treated-pentavalent-antimonials-visceral</loc><lastmod>2019-02-17T08:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-mortality-among-older-patients-treated-pentavalent-antimonials-visceral" /></url>
<url><loc>https://epicentre.msf.org/publications/accuracy-five-algorithms-diagnose-gambiense-human-african-trypanosomiasis</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/accuracy-five-algorithms-diagnose-gambiense-human-african-trypanosomiasis" /></url>
<url><loc>https://epicentre.msf.org/publications/heterogeneous-decrease-malaria-prevalence-children-over-six-year-period-south-western</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/heterogeneous-decrease-malaria-prevalence-children-over-six-year-period-south-western" /></url>
<url><loc>https://epicentre.msf.org/publications/transmission-plasmodium-vivax-south-western-uganda-report-three-cases-pregnant-women</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/transmission-plasmodium-vivax-south-western-uganda-report-three-cases-pregnant-women" /></url>
<url><loc>https://epicentre.msf.org/publications/description-and-consequences-sexual-violence-ituri-province-democratic-republic-congo</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/description-and-consequences-sexual-violence-ituri-province-democratic-republic-congo" /></url>
<url><loc>https://epicentre.msf.org/publications/against-odds-psychomotor-development-children-under-2-years-sudanese-orphanage</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/against-odds-psychomotor-development-children-under-2-years-sudanese-orphanage" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-vaccination-humanitarian-emergencies-review-recent-practice</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-vaccination-humanitarian-emergencies-review-recent-practice" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-response-immunisation-experience-chad-during-recurrent-measles-epidemics-2005</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-response-immunisation-experience-chad-during-recurrent-measles-epidemics-2005" /></url>
<url><loc>https://epicentre.msf.org/publications/brain-injury-iraqs-unseen-burden-wounded-civilians</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/brain-injury-iraqs-unseen-burden-wounded-civilians" /></url>
<url><loc>https://epicentre.msf.org/publications/estimates-duration-untreated-acute-malnutrition-children-niger</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimates-duration-untreated-acute-malnutrition-children-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/benefit-viral-load-testing-confirmation-immunological-failure-hiv-patients-treated</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/benefit-viral-load-testing-confirmation-immunological-failure-hiv-patients-treated" /></url>
<url><loc>https://epicentre.msf.org/publications/poliomyelitis-outbreak-pointe-noire-republic-congo-september-2010-february-2011</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/poliomyelitis-outbreak-pointe-noire-republic-congo-september-2010-february-2011" /></url>
<url><loc>https://epicentre.msf.org/publications/measuring-performance-vaccination-programs-using-cross-sectional-surveys-likelihood</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measuring-performance-vaccination-programs-using-cross-sectional-surveys-likelihood" /></url>
<url><loc>https://epicentre.msf.org/publications/long-lasting-measles-epidemic-maroua-cameroon-2008-2009-mass-vaccination-response</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/long-lasting-measles-epidemic-maroua-cameroon-2008-2009-mass-vaccination-response" /></url>
<url><loc>https://epicentre.msf.org/publications/cholera-epidemic-guinea-bissau-2008-importance-place</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cholera-epidemic-guinea-bissau-2008-importance-place" /></url>
<url><loc>https://epicentre.msf.org/publications/integrating-mental-health-primary-care-displaced-populations-experience-mindanao</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/integrating-mental-health-primary-care-displaced-populations-experience-mindanao" /></url>
<url><loc>https://epicentre.msf.org/publications/incidence-tuberculosis-hiv-infected-patients-and-after-starting-combined</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/incidence-tuberculosis-hiv-infected-patients-and-after-starting-combined" /></url>
<url><loc>https://epicentre.msf.org/publications/use-filter-paper-transport-medium-laboratory-diagnosis-cholera-under-field-conditions</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/use-filter-paper-transport-medium-laboratory-diagnosis-cholera-under-field-conditions" /></url>
<url><loc>https://epicentre.msf.org/publications/health-care-seeking-behavior-diarrhea-children-under-5-rural-niger-results-cross</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/health-care-seeking-behavior-diarrhea-children-under-5-rural-niger-results-cross" /></url>
<url><loc>https://epicentre.msf.org/publications/toxicity-associated-stavudine-dose-reduction-40-30-mg-first-line-antiretroviral</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/toxicity-associated-stavudine-dose-reduction-40-30-mg-first-line-antiretroviral" /></url>
<url><loc>https://epicentre.msf.org/publications/immunovirological-outcomes-and-resistance-patterns-4-years-antiretroviral-therapy-use</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/immunovirological-outcomes-and-resistance-patterns-4-years-antiretroviral-therapy-use" /></url>
<url><loc>https://epicentre.msf.org/publications/case-reactive-mass-oral-cholera-vaccinations</loc><lastmod>2019-02-17T08:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/case-reactive-mass-oral-cholera-vaccinations" /></url>
<url><loc>https://epicentre.msf.org/publications/head-head-comparison-four-artemisinin-based-combinations-treating-uncomplicated</loc><lastmod>2019-02-17T08:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/head-head-comparison-four-artemisinin-based-combinations-treating-uncomplicated" /></url>
<url><loc>https://epicentre.msf.org/publications/massive-increase-spread-and-exchange-extended-spectrum-b-lactamase-encoding-genes</loc><lastmod>2019-02-17T08:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/massive-increase-spread-and-exchange-extended-spectrum-b-lactamase-encoding-genes" /></url>
<url><loc>https://epicentre.msf.org/publications/violence-against-civilians-and-access-health-care-north-kivu-democratic-republic-congo</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/violence-against-civilians-and-access-health-care-north-kivu-democratic-republic-congo" /></url>
<url><loc>https://epicentre.msf.org/publications/reactive-vaccination-effective-tool-measles-outbreak-control-measles-mortality</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reactive-vaccination-effective-tool-measles-outbreak-control-measles-mortality" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-hotspots-and-epidemiological-connectivity</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-hotspots-and-epidemiological-connectivity" /></url>
<url><loc>https://epicentre.msf.org/publications/added-value-bleach-sedimentation-microscopy-diagnosis-tuberculosis-cost-effectiveness</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/added-value-bleach-sedimentation-microscopy-diagnosis-tuberculosis-cost-effectiveness" /></url>
<url><loc>https://epicentre.msf.org/publications/challenges-measuring-measles-case-fatality-ratios-settings-without-vital-registration</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/challenges-measuring-measles-case-fatality-ratios-settings-without-vital-registration" /></url>
<url><loc>https://epicentre.msf.org/publications/artesunate-versus-quinine-treatment-severe-falciparum-malaria-african-children-aquamat</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/artesunate-versus-quinine-treatment-severe-falciparum-malaria-african-children-aquamat" /></url>
<url><loc>https://epicentre.msf.org/publications/cryptococcal-meningitis-hiv-infected-patients-longitudinal-study-cambodia</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cryptococcal-meningitis-hiv-infected-patients-longitudinal-study-cambodia" /></url>
<url><loc>https://epicentre.msf.org/publications/acute-malnutrition-and-under-5-mortality-northeastern-part-india</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/acute-malnutrition-and-under-5-mortality-northeastern-part-india" /></url>
<url><loc>https://epicentre.msf.org/publications/episodic-outbreaks-bias-estimates-age-specific-force-infection-corrected-method-using</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/episodic-outbreaks-bias-estimates-age-specific-force-infection-corrected-method-using" /></url>
<url><loc>https://epicentre.msf.org/publications/rural-urban-gradient-seasonal-forcing-measles-transmission-niger</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/rural-urban-gradient-seasonal-forcing-measles-transmission-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/reducing-wasting-young-children-preventive-supplementation-cohort-study-niger</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reducing-wasting-young-children-preventive-supplementation-cohort-study-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/vital-status-pre-art-and-art-patients-defaulting-care-rural-malawi</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vital-status-pre-art-and-art-patients-defaulting-care-rural-malawi" /></url>
<url><loc>https://epicentre.msf.org/publications/modelling-first-dose-measles-vaccination-role-maternal-immunity-demographic-factors</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/modelling-first-dose-measles-vaccination-role-maternal-immunity-demographic-factors" /></url>
<url><loc>https://epicentre.msf.org/publications/tuberculosis-treatment-refugee-and-migrant-population-20-years-experience-thai-burmese</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/tuberculosis-treatment-refugee-and-migrant-population-20-years-experience-thai-burmese" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-ready-use-therapeutic-food-compared-cornsoy-blend-based-pre-mix</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-ready-use-therapeutic-food-compared-cornsoy-blend-based-pre-mix" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-and-safety-artemether-lumefantrine-compared-quinine-pregnant-women</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-and-safety-artemether-lumefantrine-compared-quinine-pregnant-women" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-failure-and-mortality-factors-patients-receiving-second-line-hiv-therapy</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-failure-and-mortality-factors-patients-receiving-second-line-hiv-therapy" /></url>
<url><loc>https://epicentre.msf.org/publications/meningitis-dipstick-rapid-test-evaluating-diagnostic-performance-during-urban</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/meningitis-dipstick-rapid-test-evaluating-diagnostic-performance-during-urban" /></url>
<url><loc>https://epicentre.msf.org/publications/antiretroviral-therapy-outcomes-resource-limited-settings-hiv-infected-children</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antiretroviral-therapy-outcomes-resource-limited-settings-hiv-infected-children" /></url>
<url><loc>https://epicentre.msf.org/publications/outcomes-street-children-and-youth-under-multidisciplinary-care-drop-centre</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outcomes-street-children-and-youth-under-multidisciplinary-care-drop-centre" /></url>
<url><loc>https://epicentre.msf.org/publications/prioritising-prevention-strategies-patients-antiretroviral-treatment-programmes</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prioritising-prevention-strategies-patients-antiretroviral-treatment-programmes" /></url>
<url><loc>https://epicentre.msf.org/publications/vivo-parasitological-measures-artemisinin-susceptibility</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vivo-parasitological-measures-artemisinin-susceptibility" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-three-sampling-methods-monitor-outcomes-antiretroviral-treatment-programmes</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-three-sampling-methods-monitor-outcomes-antiretroviral-treatment-programmes" /></url>
<url><loc>https://epicentre.msf.org/publications/nect-next-implementing-new-drug-combination-therapy-trypanosoma-brucei-gambiense</loc><lastmod>2019-02-17T08:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nect-next-implementing-new-drug-combination-therapy-trypanosoma-brucei-gambiense" /></url>
<url><loc>https://epicentre.msf.org/publications/access-care-non-communicable-diseases-mosul-iraq-between-2014-and-2017-rapid</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/access-care-non-communicable-diseases-mosul-iraq-between-2014-and-2017-rapid" /></url>
<url><loc>https://epicentre.msf.org/publications/demonstration-diagnostic-agreement-capillary-and-venous-blood-samples-using-hepatitis</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/demonstration-diagnostic-agreement-capillary-and-venous-blood-samples-using-hepatitis" /></url>
<url><loc>https://epicentre.msf.org/publications/cholera-epidemic-yemen-authors-reply</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cholera-epidemic-yemen-authors-reply" /></url>
<url><loc>https://epicentre.msf.org/publications/oral-cholera-vaccination-hard-reach-communities-lake-chilwa-malawi</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/oral-cholera-vaccination-hard-reach-communities-lake-chilwa-malawi" /></url>
<url><loc>https://epicentre.msf.org/publications/urban-yellow-fever-outbreak-democratic-republic-congo-2016-towards-more-rapid-case</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/urban-yellow-fever-outbreak-democratic-republic-congo-2016-towards-more-rapid-case" /></url>
<url><loc>https://epicentre.msf.org/publications/high-prevalence-infection-and-low-incidence-disease-child-contacts-patients-drug</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-prevalence-infection-and-low-incidence-disease-child-contacts-patients-drug" /></url>
<url><loc>https://epicentre.msf.org/publications/dual-screen-and-confirm-rapid-test-does-not-reduce-overtreatment-syphilis-pregnant</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/dual-screen-and-confirm-rapid-test-does-not-reduce-overtreatment-syphilis-pregnant" /></url>
<url><loc>https://epicentre.msf.org/publications/field-evaluation-near-point-care-cepheid-genexpert-hiv-1-qual-early-infant-diagnosis</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/field-evaluation-near-point-care-cepheid-genexpert-hiv-1-qual-early-infant-diagnosis" /></url>
<url><loc>https://epicentre.msf.org/publications/reply</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reply" /></url>
<url><loc>https://epicentre.msf.org/publications/barriers-access-visceral-leishmaniasis-diagnosis-and-care-among-seasonal-mobile</loc><lastmod>2019-02-18T15:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/barriers-access-visceral-leishmaniasis-diagnosis-and-care-among-seasonal-mobile" /></url>
<url><loc>https://epicentre.msf.org/publications/retention-care-among-clinically-stable-antiretroviral-therapy-patients-following-six</loc><lastmod>2019-02-18T15:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/retention-care-among-clinically-stable-antiretroviral-therapy-patients-following-six" /></url>
<url><loc>https://epicentre.msf.org/publications/extremely-low-hepatitis-c-prevalence-among-hiv-co-infected-individuals-four-countries</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/extremely-low-hepatitis-c-prevalence-among-hiv-co-infected-individuals-four-countries" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-test-and-treat-recommendations-eligibility-antiretroviral-treatment-cross</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-test-and-treat-recommendations-eligibility-antiretroviral-treatment-cross" /></url>
<url><loc>https://epicentre.msf.org/publications/complex-interactions-between-malaria-and-malnutrition-systematic-literature-review</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/complex-interactions-between-malaria-and-malnutrition-systematic-literature-review" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-vaginal-colonization-and-relationship-between-bacterial-vaginal</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-vaginal-colonization-and-relationship-between-bacterial-vaginal" /></url>
<url><loc>https://epicentre.msf.org/publications/antimicrobial-treatment-practices-among-ugandan-children-suspicion-central-nervous</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antimicrobial-treatment-practices-among-ugandan-children-suspicion-central-nervous" /></url>
<url><loc>https://epicentre.msf.org/publications/hiv-treatment-associated-two-fold-higher-probability-raised-triglycerides-pooled</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/hiv-treatment-associated-two-fold-higher-probability-raised-triglycerides-pooled" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-and-vaccination-coverage-hepatitis-b-among-healthcare-workers-cameroon</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-and-vaccination-coverage-hepatitis-b-among-healthcare-workers-cameroon" /></url>
<url><loc>https://epicentre.msf.org/publications/muac-sole-discharge-criterion-community-based-management-severe-acute-malnutrition</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/muac-sole-discharge-criterion-community-based-management-severe-acute-malnutrition" /></url>
<url><loc>https://epicentre.msf.org/publications/field-evaluation-genexpert-cepheid-hcv-performance-rna-quantification-genotype-1-and-6</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/field-evaluation-genexpert-cepheid-hcv-performance-rna-quantification-genotype-1-and-6" /></url>
<url><loc>https://epicentre.msf.org/publications/life-waiting-refugees-mental-health-and-narratives-social-suffering-after-european</loc><lastmod>2019-02-18T15:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/life-waiting-refugees-mental-health-and-narratives-social-suffering-after-european" /></url>
<url><loc>https://epicentre.msf.org/publications/population-level-hiv-incidence-estimates-using-combination-synthetic-cohort-and</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/population-level-hiv-incidence-estimates-using-combination-synthetic-cohort-and" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-correlates-successful-outcomes-pulmonary-multidrug-resistant-tuberculosis</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-correlates-successful-outcomes-pulmonary-multidrug-resistant-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/progress-and-challenges-using-oral-cholera-vaccines-control-outbreaks-medecins-sans</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/progress-and-challenges-using-oral-cholera-vaccines-control-outbreaks-medecins-sans" /></url>
<url><loc>https://epicentre.msf.org/publications/safety-rvsv-zebov-vaccine-against-ebola-zaire-among-frontline-workers-guinea</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/safety-rvsv-zebov-vaccine-against-ebola-zaire-among-frontline-workers-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-pneumococcal-meningitis-paoua-subprefecture-central-african-republic-2016</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-pneumococcal-meningitis-paoua-subprefecture-central-african-republic-2016" /></url>
<url><loc>https://epicentre.msf.org/publications/acceptability-and-utilization-three-nutritional-supplements-during-pregnancy-findings</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/acceptability-and-utilization-three-nutritional-supplements-during-pregnancy-findings" /></url>
<url><loc>https://epicentre.msf.org/publications/protection-young-children-cholera-vaccine</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/protection-young-children-cholera-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/advancing-equitable-global-health-research-partnerships-africa</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/advancing-equitable-global-health-research-partnerships-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/single-dose-oral-ciprofloxacin-prophylaxis-response-meningococcal-meningitis-epidemic</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/single-dose-oral-ciprofloxacin-prophylaxis-response-meningococcal-meningitis-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/6-months-bedaquiline-enough-results-compassionate-use-bedaquiline-armenia-and-georgia</loc><lastmod>2019-02-18T15:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/6-months-bedaquiline-enough-results-compassionate-use-bedaquiline-armenia-and-georgia" /></url>
<url><loc>https://epicentre.msf.org/publications/identifying-human-encounters-shape-transmission-streptococcus-pneumoniae-and-other</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/identifying-human-encounters-shape-transmission-streptococcus-pneumoniae-and-other" /></url>
<url><loc>https://epicentre.msf.org/publications/hiv-1-drug-resistance-testing-second-line-regimen-failure-arua-uganda-avoiding</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/hiv-1-drug-resistance-testing-second-line-regimen-failure-arua-uganda-avoiding" /></url>
<url><loc>https://epicentre.msf.org/publications/estimating-program-coverage-treatment-severe-acute-malnutrition-comparative-analysis</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimating-program-coverage-treatment-severe-acute-malnutrition-comparative-analysis" /></url>
<url><loc>https://epicentre.msf.org/publications/determinants-dietary-practices-during-pregnancy-longitudinal-qualitative-study-niger</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/determinants-dietary-practices-during-pregnancy-longitudinal-qualitative-study-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/depression-and-suicidal-ideation-among-hiv-infected-adults-receiving-efavirenz-versus</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/depression-and-suicidal-ideation-among-hiv-infected-adults-receiving-efavirenz-versus" /></url>
<url><loc>https://epicentre.msf.org/publications/cyp2b6-genetic-polymorphisms-depression-and-viral-suppression-adults-living-hiv</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cyp2b6-genetic-polymorphisms-depression-and-viral-suppression-adults-living-hiv" /></url>
<url><loc>https://epicentre.msf.org/publications/bedaquiline-and-repurposed-drugs-fluoroquinolone-resistant-multidrug-resistant</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/bedaquiline-and-repurposed-drugs-fluoroquinolone-resistant-multidrug-resistant" /></url>
<url><loc>https://epicentre.msf.org/publications/dynamic-model-transmission-and-elimination-peste-des-petits-ruminants-ethiopia</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/dynamic-model-transmission-and-elimination-peste-des-petits-ruminants-ethiopia" /></url>
<url><loc>https://epicentre.msf.org/publications/xpert-mtbrif-diagnosis-childhood-tuberculosis-sputum-and-stool-samples-high-tb-hiv</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/xpert-mtbrif-diagnosis-childhood-tuberculosis-sputum-and-stool-samples-high-tb-hiv" /></url>
<url><loc>https://epicentre.msf.org/publications/voluntary-community-human-immunodeficiency-virus-testing-linkage-and-retention-care</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/voluntary-community-human-immunodeficiency-virus-testing-linkage-and-retention-care" /></url>
<url><loc>https://epicentre.msf.org/publications/sub-national-variation-measles-vaccine-coverage-and-outbreak-risk-case-study-2010</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sub-national-variation-measles-vaccine-coverage-and-outbreak-risk-case-study-2010" /></url>
<url><loc>https://epicentre.msf.org/publications/safety-heat-stable-rotavirus-vaccine-among-children-niger-data-phase-3-randomized</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/safety-heat-stable-rotavirus-vaccine-among-children-niger-data-phase-3-randomized" /></url>
<url><loc>https://epicentre.msf.org/publications/near-real-time-forecasting-cholera-decision-making-haiti-after-hurricane-matthew</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/near-real-time-forecasting-cholera-decision-making-haiti-after-hurricane-matthew" /></url>
<url><loc>https://epicentre.msf.org/publications/micro-hotspots-risk-urban-cholera-epidemics</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/micro-hotspots-risk-urban-cholera-epidemics" /></url>
<url><loc>https://epicentre.msf.org/publications/highly-targeted-cholera-vaccination-campaigns-urban-setting-are-feasible-experience</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/highly-targeted-cholera-vaccination-campaigns-urban-setting-are-feasible-experience" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-sd-bioline-cholera-rapid-diagnostic-test-during-2016-cholera-outbreak</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-sd-bioline-cholera-rapid-diagnostic-test-during-2016-cholera-outbreak" /></url>
<url><loc>https://epicentre.msf.org/publications/distribution-and-performance-cardiovascular-risk-scores-mixed-population-hiv-infected</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/distribution-and-performance-cardiovascular-risk-scores-mixed-population-hiv-infected" /></url>
<url><loc>https://epicentre.msf.org/publications/cholera-epidemic-yemen-2016-18-analysis-surveillance-data</loc><lastmod>2019-02-18T15:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cholera-epidemic-yemen-2016-18-analysis-surveillance-data" /></url>
<url><loc>https://epicentre.msf.org/publications/artemether-lumefantrine-dosing-malaria-treatment-young-children-and-pregnant-women</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/artemether-lumefantrine-dosing-malaria-treatment-young-children-and-pregnant-women" /></url>
<url><loc>https://epicentre.msf.org/publications/inequality-outcomes-adolescents-living-perinatally-acquired-hiv-sub-saharan-africa</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/inequality-outcomes-adolescents-living-perinatally-acquired-hiv-sub-saharan-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/characteristics-human-encounters-and-social-mixing-patterns-relevant-infectious</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/characteristics-human-encounters-and-social-mixing-patterns-relevant-infectious" /></url>
<url><loc>https://epicentre.msf.org/publications/hiv-associated-kaposis-sarcoma-maputo-mozambique-outcomes-specialized-treatment-center</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/hiv-associated-kaposis-sarcoma-maputo-mozambique-outcomes-specialized-treatment-center" /></url>
<url><loc>https://epicentre.msf.org/publications/new-who-decision-making-framework-vaccine-use-acute-humanitarian-emergencies-msf</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/new-who-decision-making-framework-vaccine-use-acute-humanitarian-emergencies-msf" /></url>
<url><loc>https://epicentre.msf.org/publications/tackling-mortality-due-childhood-tuberculosis</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/tackling-mortality-due-childhood-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/pharmacokinetics-efavirenz-patients-antituberculosis-treatment-high-human</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pharmacokinetics-efavirenz-patients-antituberculosis-treatment-high-human" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-different-treatments-isoniazid-resistant-tuberculosis-individual-patient</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-different-treatments-isoniazid-resistant-tuberculosis-individual-patient" /></url>
<url><loc>https://epicentre.msf.org/publications/syrian-refugees-greece-experience-violence-mental-health-status-and-access-information</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/syrian-refugees-greece-experience-violence-mental-health-status-and-access-information" /></url>
<url><loc>https://epicentre.msf.org/publications/progress-towards-unaids-90-90-90-goals-age-and-gender-rural-area-kwazulu-natal-south</loc><lastmod>2019-02-18T15:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/progress-towards-unaids-90-90-90-goals-age-and-gender-rural-area-kwazulu-natal-south" /></url>
<url><loc>https://epicentre.msf.org/publications/outcomes-hiv-infected-versus-hiv-non-infected-patients-treated-drug-resistance</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outcomes-hiv-infected-versus-hiv-non-infected-patients-treated-drug-resistance" /></url>
<url><loc>https://epicentre.msf.org/publications/mapping-burden-cholera-sub-saharan-africa-and-implications-control-analysis-data</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mapping-burden-cholera-sub-saharan-africa-and-implications-control-analysis-data" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-and-nutritional-status-among-children-severe-acute-malnutrition-niger</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-and-nutritional-status-among-children-severe-acute-malnutrition-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/high-proportions-patients-advanced-hiv-are-antiretroviral-therapy-experienced</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-proportions-patients-advanced-hiv-are-antiretroviral-therapy-experienced" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-measles-mortality-and-importance-decentralized-case-management-during</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-measles-mortality-and-importance-decentralized-case-management-during" /></url>
<url><loc>https://epicentre.msf.org/publications/potential-impact-case-area-targeted-interventions-response-cholera-outbreaks-modeling</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/potential-impact-case-area-targeted-interventions-response-cholera-outbreaks-modeling" /></url>
<url><loc>https://epicentre.msf.org/publications/molecular-markers-resistance-amodiaquine-plus-sulfadoxine-pyrimethamine-area-seasonal</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/molecular-markers-resistance-amodiaquine-plus-sulfadoxine-pyrimethamine-area-seasonal" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemiology-adolescents-living-perinatally-acquired-hiv-cross-region-global-cohort</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemiology-adolescents-living-perinatally-acquired-hiv-cross-region-global-cohort" /></url>
<url><loc>https://epicentre.msf.org/publications/high-prevalence-or-enteroinvasive-carriage-among-residents-internally-displaced</loc><lastmod>2019-02-18T15:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-prevalence-or-enteroinvasive-carriage-among-residents-internally-displaced" /></url>
<url><loc>https://epicentre.msf.org/publications/infant-formula-iraq-part-problem-and-not-simple-solution-authors-reply</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/infant-formula-iraq-part-problem-and-not-simple-solution-authors-reply" /></url>
<url><loc>https://epicentre.msf.org/publications/hiv-infection-and-risk-postpartum-infection-complications-and-mortality-rural-uganda</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/hiv-infection-and-risk-postpartum-infection-complications-and-mortality-rural-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/whats-coming-health-science-and-policy-2018-global-experts-look-ahead-their-field</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/whats-coming-health-science-and-policy-2018-global-experts-look-ahead-their-field" /></url>
<url><loc>https://epicentre.msf.org/publications/single-dose-cholera-vaccine-response-outbreak-zambia</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/single-dose-cholera-vaccine-response-outbreak-zambia" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-treatment-and-re-treatment-artemether-lumefantrine-and-artesunate-amodiaquine</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-treatment-and-re-treatment-artemether-lumefantrine-and-artesunate-amodiaquine" /></url>
<url><loc>https://epicentre.msf.org/publications/dried-blood-spots-measuring-vibrio-cholerae-specific-immune-responses</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/dried-blood-spots-measuring-vibrio-cholerae-specific-immune-responses" /></url>
<url><loc>https://epicentre.msf.org/publications/unreported-cases-2014-2016-ebola-epidemic-spatiotemporal-variation-and-implications</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/unreported-cases-2014-2016-ebola-epidemic-spatiotemporal-variation-and-implications" /></url>
<url><loc>https://epicentre.msf.org/publications/high-rates-hypertension-diabetes-elevated-low-density-lipoprotein-cholesterol-and</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-rates-hypertension-diabetes-elevated-low-density-lipoprotein-cholesterol-and" /></url>
<url><loc>https://epicentre.msf.org/publications/single-low-dose-primaquine-blocking-transmission-plasmodium-falciparum-malaria</loc><lastmod>2019-02-18T15:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/single-low-dose-primaquine-blocking-transmission-plasmodium-falciparum-malaria" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-artesunate-amodiaquine-dihydroartemisinin-piperaquine-and-artemether</loc><lastmod>2019-02-18T15:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-artesunate-amodiaquine-dihydroartemisinin-piperaquine-and-artemether" /></url>
<url><loc>https://epicentre.msf.org/publications/brief-report-higher-art-adherence-associated-lower-systemic-inflammation-treatment</loc><lastmod>2019-02-18T15:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/brief-report-higher-art-adherence-associated-lower-systemic-inflammation-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-outcomes-and-tolerability-revised-who-anti-tuberculosis-drug-dosages</loc><lastmod>2019-02-18T15:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-outcomes-and-tolerability-revised-who-anti-tuberculosis-drug-dosages" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-biologic-and-non-biologic-antirheumatic-drugs-anaemia-markers-153788</loc><lastmod>2019-02-18T15:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-biologic-and-non-biologic-antirheumatic-drugs-anaemia-markers-153788" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-virological-failure-and-subtherapeutic-antiretroviral-drug-concentrations</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-virological-failure-and-subtherapeutic-antiretroviral-drug-concentrations" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-5-year-programme-prevent-mother-child-transmission-hiv-infection-northern</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-5-year-programme-prevent-mother-child-transmission-hiv-infection-northern" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-three-parasite-lactate-dehydrogenase-based-rapid-diagnostic-tests-diagnosis</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-three-parasite-lactate-dehydrogenase-based-rapid-diagnostic-tests-diagnosis" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-melarsoprol-and-eflornithine-first-line-regimens-gambiense-sleeping</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-melarsoprol-and-eflornithine-first-line-regimens-gambiense-sleeping" /></url>
<url><loc>https://epicentre.msf.org/publications/dihydroartemisinin-piperaquine-and-artemether-lumefantrine-treating-uncomplicated</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/dihydroartemisinin-piperaquine-and-artemether-lumefantrine-treating-uncomplicated" /></url>
<url><loc>https://epicentre.msf.org/publications/public-health-cholera-crisis-africa</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/public-health-cholera-crisis-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-fastplaquetb-diagnose-smear-negative-tuberculosis-peripheral-clinic-kenya</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-fastplaquetb-diagnose-smear-negative-tuberculosis-peripheral-clinic-kenya" /></url>
<url><loc>https://epicentre.msf.org/publications/varying-efficacy-artesunateamodiaquine-and-artesunatesulphadoxine-pyrimethamine</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/varying-efficacy-artesunateamodiaquine-and-artesunatesulphadoxine-pyrimethamine" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-patients-lost-follow-antiretroviral-treatment-programmes-resource-limited</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-patients-lost-follow-antiretroviral-treatment-programmes-resource-limited" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-new-world-health-organization-growth-standards-and-national-center-health</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-new-world-health-organization-growth-standards-and-national-center-health" /></url>
<url><loc>https://epicentre.msf.org/publications/large-scale-distribution-milk-based-fortified-spreads-evidence-new-approach-regions</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/large-scale-distribution-milk-based-fortified-spreads-evidence-new-approach-regions" /></url>
<url><loc>https://epicentre.msf.org/publications/trauma-related-psychological-disorders-among-palestinian-children-and-adults-gaza-and</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/trauma-related-psychological-disorders-among-palestinian-children-and-adults-gaza-and" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-study-yaws-democratic-republic-congo-using-lot-quality-assurance-sampling</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-study-yaws-democratic-republic-congo-using-lot-quality-assurance-sampling" /></url>
<url><loc>https://epicentre.msf.org/publications/learning-lessons-field-surveys-humanitarian-contexts-case-study-field-surveys</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/learning-lessons-field-surveys-humanitarian-contexts-case-study-field-surveys" /></url>
<url><loc>https://epicentre.msf.org/publications/malnutrition-and-mortality-patterns-among-internally-displaced-and-non-displaced</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malnutrition-and-mortality-patterns-among-internally-displaced-and-non-displaced" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-psychological-support-victims-sexual-violence-conflict-setting-results</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-psychological-support-victims-sexual-violence-conflict-setting-results" /></url>
<url><loc>https://epicentre.msf.org/publications/assessing-impact-introduction-world-health-organization-growth-standards-and-weight</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/assessing-impact-introduction-world-health-organization-growth-standards-and-weight" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-and-risk-factors-lassa-seropositivity-inhabitants-forest-region-guinea</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-and-risk-factors-lassa-seropositivity-inhabitants-forest-region-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/look-back-ongoing-problem-shigella-dysenteriae-type-1-epidemics-refugee-settings</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/look-back-ongoing-problem-shigella-dysenteriae-type-1-epidemics-refugee-settings" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-risk-among-children-admitted-large-scale-nutritional-program-niger-2006</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-risk-among-children-admitted-large-scale-nutritional-program-niger-2006" /></url>
<url><loc>https://epicentre.msf.org/publications/prognostic-accuracy-who-growth-standards-predict-mortality-large-scale-nutritional</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prognostic-accuracy-who-growth-standards-predict-mortality-large-scale-nutritional" /></url>
<url><loc>https://epicentre.msf.org/publications/weight-gain-3-months-antiretroviral-therapy-strongly-associated-survival-evidence-two</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/weight-gain-3-months-antiretroviral-therapy-strongly-associated-survival-evidence-two" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-shift-nchs-growth-reference-who2006-growth-standards-therapeutic-feeding</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-shift-nchs-growth-reference-who2006-growth-standards-therapeutic-feeding" /></url>
<url><loc>https://epicentre.msf.org/publications/characteristics-drug-resistant-tuberculosis-abkhazia-georgia-high-prevalence-area</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/characteristics-drug-resistant-tuberculosis-abkhazia-georgia-high-prevalence-area" /></url>
<url><loc>https://epicentre.msf.org/publications/multiple-origins-and-regional-dispersal-resistant-dhps-african-plasmodium-falciparum</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/multiple-origins-and-regional-dispersal-resistant-dhps-african-plasmodium-falciparum" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-buruli-ulcer-akonolinga-health-district-cameroon-results-cross-sectional</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-buruli-ulcer-akonolinga-health-district-cameroon-results-cross-sectional" /></url>
<url><loc>https://epicentre.msf.org/publications/nifurtimox-eflornithine-combination-therapy-second-stage-african-trypanosoma-brucei</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nifurtimox-eflornithine-combination-therapy-second-stage-african-trypanosoma-brucei" /></url>
<url><loc>https://epicentre.msf.org/publications/sputum-sex-and-scanty-smears-new-case-definition-may-reduce-sex-disparities-smear</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sputum-sex-and-scanty-smears-new-case-definition-may-reduce-sex-disparities-smear" /></url>
<url><loc>https://epicentre.msf.org/publications/field-evaluation-two-rapid-diagnostic-tests-neisseria-meningitidis-serogroup-during</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/field-evaluation-two-rapid-diagnostic-tests-neisseria-meningitidis-serogroup-during" /></url>
<url><loc>https://epicentre.msf.org/publications/colombian-conflict-description-mental-health-program-department-tolima</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/colombian-conflict-description-mental-health-program-department-tolima" /></url>
<url><loc>https://epicentre.msf.org/publications/burden-disease-and-circulating-serotypes-rotavirus-infection-sub-saharan-africa</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/burden-disease-and-circulating-serotypes-rotavirus-infection-sub-saharan-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/estimates-measles-case-fatality-ratios-comprehensive-review-community-based-studies</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimates-measles-case-fatality-ratios-comprehensive-review-community-based-studies" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-artesunate-amodiaquine-treating-uncomplicated-falciparum-malaria-sub-saharan</loc><lastmod>2019-02-18T15:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-artesunate-amodiaquine-treating-uncomplicated-falciparum-malaria-sub-saharan" /></url>
<url><loc>https://epicentre.msf.org/publications/use-lot-quality-assurance-sampling-lqas-estimate-vaccination-coverage-helps-guide</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/use-lot-quality-assurance-sampling-lqas-estimate-vaccination-coverage-helps-guide" /></url>
<url><loc>https://epicentre.msf.org/publications/different-methodological-approaches-assessment-vivo-efficacy-three-artemisinin-based</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/different-methodological-approaches-assessment-vivo-efficacy-three-artemisinin-based" /></url>
<url><loc>https://epicentre.msf.org/publications/bleach-sedimentation-opportunity-optimize-smear-microscopy-tuberculosis-diagnosis</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/bleach-sedimentation-opportunity-optimize-smear-microscopy-tuberculosis-diagnosis" /></url>
<url><loc>https://epicentre.msf.org/publications/research-complex-humanitarian-emergencies-medecins-sans-frontieresepicentre-experience</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/research-complex-humanitarian-emergencies-medecins-sans-frontieresepicentre-experience" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-severe-malnutrition-2-day-intramuscular-ceftriaxone-vs-5-day-amoxicillin</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-severe-malnutrition-2-day-intramuscular-ceftriaxone-vs-5-day-amoxicillin" /></url>
<url><loc>https://epicentre.msf.org/publications/dynamics-measles-sub-saharan-africa</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/dynamics-measles-sub-saharan-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/assessment-three-new-parasite-lactate-dehydrogenase-pan-pldh-tests-diagnosis</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/assessment-three-new-parasite-lactate-dehydrogenase-pan-pldh-tests-diagnosis" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-yellow-fever-concurrent-chikungunya-virus-transmission-south-kordofan-sudan</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-yellow-fever-concurrent-chikungunya-virus-transmission-south-kordofan-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/verbosity-epidemic</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/verbosity-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/time-essence-exploring-measles-outbreak-response-vaccination-niamey-niger</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/time-essence-exploring-measles-outbreak-response-vaccination-niamey-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/immunogenicity-fractional-doses-tetravalent-acyw135-meningococcal-polysaccharide</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/immunogenicity-fractional-doses-tetravalent-acyw135-meningococcal-polysaccharide" /></url>
<url><loc>https://epicentre.msf.org/publications/assessing-antimalarial-efficacy-time-change-artemisinin-based-combination-therapies</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/assessing-antimalarial-efficacy-time-change-artemisinin-based-combination-therapies" /></url>
<url><loc>https://epicentre.msf.org/publications/relationship-between-haemoglobin-concentration-and-haematocrit-plasmodium-falciparum</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/relationship-between-haemoglobin-concentration-and-haematocrit-plasmodium-falciparum" /></url>
<url><loc>https://epicentre.msf.org/publications/violence-related-mortality-iraq-2002-2006</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/violence-related-mortality-iraq-2002-2006" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-associated-asymptomatic-parasitaemia-occurring-post-antimalarial-treatment</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-associated-asymptomatic-parasitaemia-occurring-post-antimalarial-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/safety-and-effectiveness-first-line-eflornithine-trypanosoma-brucei-gambiense-sleeping</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/safety-and-effectiveness-first-line-eflornithine-trypanosoma-brucei-gambiense-sleeping" /></url>
<url><loc>https://epicentre.msf.org/publications/second-line-antiretroviral-therapy-resource-limited-settings-experience-medecins-sans</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/second-line-antiretroviral-therapy-resource-limited-settings-experience-medecins-sans" /></url>
<url><loc>https://epicentre.msf.org/publications/population-pharmacokinetics-piperaquine-after-two-different-treatment-regimens</loc><lastmod>2019-02-18T15:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/population-pharmacokinetics-piperaquine-after-two-different-treatment-regimens" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-beriberi-prison-cote-divoire</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-beriberi-prison-cote-divoire" /></url>
<url><loc>https://epicentre.msf.org/publications/reducing-number-sputum-samples-examined-and-thresholds-positivity-opportunity-optimise</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/reducing-number-sputum-samples-examined-and-thresholds-positivity-opportunity-optimise" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-antimalarial-treatment-guinea-vivo-study-two-artemisinin-combination</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-antimalarial-treatment-guinea-vivo-study-two-artemisinin-combination" /></url>
<url><loc>https://epicentre.msf.org/publications/optimisation-t-square-sampling-method-estimate-population-sizes</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/optimisation-t-square-sampling-method-estimate-population-sizes" /></url>
<url><loc>https://epicentre.msf.org/publications/biological-diagnosis-meningococcal-meningitis-african-meningitis-belt-current-epidemic</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/biological-diagnosis-meningococcal-meningitis-african-meningitis-belt-current-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/nifurtimox-plus-eflornithine-late-stage-sleeping-sickness-uganda-case-series</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nifurtimox-plus-eflornithine-late-stage-sleeping-sickness-uganda-case-series" /></url>
<url><loc>https://epicentre.msf.org/publications/ecological-study-socio-economic-indicators-and-prevalence-asthma-schoolchildren-urban</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ecological-study-socio-economic-indicators-and-prevalence-asthma-schoolchildren-urban" /></url>
<url><loc>https://epicentre.msf.org/publications/positive-outcomes-haart-24-months-hiv-infected-patients-cambodia</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/positive-outcomes-haart-24-months-hiv-infected-patients-cambodia" /></url>
<url><loc>https://epicentre.msf.org/publications/could-nutritional-rehabilitation-home-complement-or-replace-centre-based-therapeutic</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/could-nutritional-rehabilitation-home-complement-or-replace-centre-based-therapeutic" /></url>
<url><loc>https://epicentre.msf.org/publications/community-coverage-antimalarial-combination-artesunate-and-amodiaquine-makamba</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/community-coverage-antimalarial-combination-artesunate-and-amodiaquine-makamba" /></url>
<url><loc>https://epicentre.msf.org/publications/dont-spin-pen-two-alternative-methods-second-stage-sampling-urban-cluster-surveys</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/dont-spin-pen-two-alternative-methods-second-stage-sampling-urban-cluster-surveys" /></url>
<url><loc>https://epicentre.msf.org/publications/unacceptably-high-mortality-related-measles-epidemics-niger-nigeria-and-chad</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/unacceptably-high-mortality-related-measles-epidemics-niger-nigeria-and-chad" /></url>
<url><loc>https://epicentre.msf.org/publications/using-european-travellers-early-alert-detect-emerging-pathogens-countries-limited</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/using-european-travellers-early-alert-detect-emerging-pathogens-countries-limited" /></url>
<url><loc>https://epicentre.msf.org/publications/death-rates-malaria-epidemics-burundi-and-ethiopia</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/death-rates-malaria-epidemics-burundi-and-ethiopia" /></url>
<url><loc>https://epicentre.msf.org/publications/relapses-plasmodium-vivax-infection-usually-result-activation-heterologous-hypnozoites</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/relapses-plasmodium-vivax-infection-usually-result-activation-heterologous-hypnozoites" /></url>
<url><loc>https://epicentre.msf.org/publications/response-highly-active-antiretroviral-therapy-among-severely-immuno-compromised-hiv</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/response-highly-active-antiretroviral-therapy-among-severely-immuno-compromised-hiv" /></url>
<url><loc>https://epicentre.msf.org/publications/prevalence-determinants-positivity-and-clinical-utility-cryptococcal-antigenemia</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/prevalence-determinants-positivity-and-clinical-utility-cryptococcal-antigenemia" /></url>
<url><loc>https://epicentre.msf.org/publications/molecular-genotyping-malaria-treatment-trial-uganda-unexpected-high-rate-new</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/molecular-genotyping-malaria-treatment-trial-uganda-unexpected-high-rate-new" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-and-safety-dihydroartemisinin-piperaquine</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-and-safety-dihydroartemisinin-piperaquine" /></url>
<url><loc>https://epicentre.msf.org/publications/electrocardiographic-safety-evaluation-dihydroartemisinin-piperaquine-treatment</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/electrocardiographic-safety-evaluation-dihydroartemisinin-piperaquine-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/meningitis-serogroup-w135-outbreak-burkina-faso-2002</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/meningitis-serogroup-w135-outbreak-burkina-faso-2002" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-outcomes-stratified-baseline-immunological-status-among-young-children</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-outcomes-stratified-baseline-immunological-status-among-young-children" /></url>
<url><loc>https://epicentre.msf.org/publications/world-antimalarial-resistance-network-i-clinical-efficacy-antimalarial-drugs</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/world-antimalarial-resistance-network-i-clinical-efficacy-antimalarial-drugs" /></url>
<url><loc>https://epicentre.msf.org/publications/nifurtimox-eflornithine-combination-therapy-second-stage-trypanosoma-brucei-gambiense</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/nifurtimox-eflornithine-combination-therapy-second-stage-trypanosoma-brucei-gambiense" /></url>
<url><loc>https://epicentre.msf.org/publications/paracheck-pf-accuracy-and-recently-treated-plasmodium-falciparum-infections-there-risk</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/paracheck-pf-accuracy-and-recently-treated-plasmodium-falciparum-infections-there-risk" /></url>
<url><loc>https://epicentre.msf.org/publications/short-communication-antituberculosis-drug-induced-hepatotoxicity-unexpectedly-low-hiv</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/short-communication-antituberculosis-drug-induced-hepatotoxicity-unexpectedly-low-hiv" /></url>
<url><loc>https://epicentre.msf.org/publications/drug-policy-visceral-leishmaniasis-cost-effectiveness-analysis</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/drug-policy-visceral-leishmaniasis-cost-effectiveness-analysis" /></url>
<url><loc>https://epicentre.msf.org/publications/clonal-reconquest-antibiotic-susceptible-salmonella-enterica-serotype-typhi-son-la</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/clonal-reconquest-antibiotic-susceptible-salmonella-enterica-serotype-typhi-son-la" /></url>
<url><loc>https://epicentre.msf.org/publications/wanted-studies-mortality-estimation-methods-humanitarian-emergencies-suggestions</loc><lastmod>2019-02-18T15:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/wanted-studies-mortality-estimation-methods-humanitarian-emergencies-suggestions" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-tetanus-cases-following-tsunami-aceh-province-indonesia</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-tetanus-cases-following-tsunami-aceh-province-indonesia" /></url>
<url><loc>https://epicentre.msf.org/publications/high-mortality-internally-displaced-population-ituri-democratic-republic-congo-2005</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-mortality-internally-displaced-population-ituri-democratic-republic-congo-2005" /></url>
<url><loc>https://epicentre.msf.org/publications/high-mortality-associated-outbreak-hepatitis-e-among-displaced-persons-darfur-sudan</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-mortality-associated-outbreak-hepatitis-e-among-displaced-persons-darfur-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/tuberculosis-after-haart-initiation-hiv-positive-patients-five-countries-high</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/tuberculosis-after-haart-initiation-hiv-positive-patients-five-countries-high" /></url>
<url><loc>https://epicentre.msf.org/publications/high-sensitivity-and-specificity-pastorex-latex-agglutination-test-neisseria</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-sensitivity-and-specificity-pastorex-latex-agglutination-test-neisseria" /></url>
<url><loc>https://epicentre.msf.org/publications/generic-fixed-dose-combination-antiretroviral-treatment-resource-poor-settings</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/generic-fixed-dose-combination-antiretroviral-treatment-resource-poor-settings" /></url>
<url><loc>https://epicentre.msf.org/publications/pharyngeal-carriage-neisseria-meningitidis-2-19-year-old-individuals-uganda</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pharyngeal-carriage-neisseria-meningitidis-2-19-year-old-individuals-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/feasibility-mass-vaccination-campaign-using-two-dose-oral-cholera-vaccine-urban</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/feasibility-mass-vaccination-campaign-using-two-dose-oral-cholera-vaccine-urban" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-epidemics-and-interventions-kenya-burundi-southern-sudan-and-ethiopia-1999</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-epidemics-and-interventions-kenya-burundi-southern-sudan-and-ethiopia-1999" /></url>
<url><loc>https://epicentre.msf.org/publications/supervised-versus-unsupervised-antimalarial-treatment-six-dose-artemether-lumefantrine</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/supervised-versus-unsupervised-antimalarial-treatment-six-dose-artemether-lumefantrine" /></url>
<url><loc>https://epicentre.msf.org/publications/short-report-molecular-markers-associated-plasmodium-falciparum-resistance-sulfadoxine</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/short-report-molecular-markers-associated-plasmodium-falciparum-resistance-sulfadoxine" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-chloroquine-and-sulfadoxinepyrimethamine-treatment-uncomplicated-falciparum</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-chloroquine-and-sulfadoxinepyrimethamine-treatment-uncomplicated-falciparum" /></url>
<url><loc>https://epicentre.msf.org/publications/pre-emptive-war-epidemiology-lessons-democratic-republic-congo</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pre-emptive-war-epidemiology-lessons-democratic-republic-congo" /></url>
<url><loc>https://epicentre.msf.org/publications/late-vaccination-reinforcement-during-measles-epidemic-niamey-niger-2003-2004</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/late-vaccination-reinforcement-during-measles-epidemic-niamey-niger-2003-2004" /></url>
<url><loc>https://epicentre.msf.org/publications/validation-single-real-time-taqman-pcr-assay-detection-and-quantitation-four-major</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/validation-single-real-time-taqman-pcr-assay-detection-and-quantitation-four-major" /></url>
<url><loc>https://epicentre.msf.org/publications/scaling-highly-active-antiretroviral-therapy-rural-district-malawi-effectiveness</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/scaling-highly-active-antiretroviral-therapy-rural-district-malawi-effectiveness" /></url>
<url><loc>https://epicentre.msf.org/publications/estimating-transmission-intensity-measles-epidemic-niamey-niger-lessons-intervention</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/estimating-transmission-intensity-measles-epidemic-niamey-niger-lessons-intervention" /></url>
<url><loc>https://epicentre.msf.org/publications/are-rapid-population-estimates-accurate-field-trial-two-different-assessment-methods</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/are-rapid-population-estimates-accurate-field-trial-two-different-assessment-methods" /></url>
<url><loc>https://epicentre.msf.org/publications/exploring-time-intervene-reactive-mass-vaccination-campaign-measles-epidemics</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/exploring-time-intervene-reactive-mass-vaccination-campaign-measles-epidemics" /></url>
<url><loc>https://epicentre.msf.org/publications/low-efficacy-combination-artesunate-plus-amodiaquine-uncomplicated-falciparum-malaria</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/low-efficacy-combination-artesunate-plus-amodiaquine-uncomplicated-falciparum-malaria" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-chloroquine-sulfadoxine-pyrimethamine-and-amodiaquine-treatment-uncomplicated</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-chloroquine-sulfadoxine-pyrimethamine-and-amodiaquine-treatment-uncomplicated" /></url>
<url><loc>https://epicentre.msf.org/publications/methodological-issues-assessment-antimalarial-drug-treatment-analysis-13-studies-eight</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/methodological-issues-assessment-antimalarial-drug-treatment-analysis-13-studies-eight" /></url>
<url><loc>https://epicentre.msf.org/publications/large-outbreak-hepatitis-e-among-displaced-population-darfur-sudan-2004-role-water</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/large-outbreak-hepatitis-e-among-displaced-population-darfur-sudan-2004-role-water" /></url>
<url><loc>https://epicentre.msf.org/publications/high-efficacy-two-artemisinin-based-combinations-artesunate-amodiaquine-and-artemether</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-efficacy-two-artemisinin-based-combinations-artesunate-amodiaquine-and-artemether" /></url>
<url><loc>https://epicentre.msf.org/publications/resource-limited-settings-good-early-outcomes-can-be-achieved-children-using-adult</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/resource-limited-settings-good-early-outcomes-can-be-achieved-children-using-adult" /></url>
<url><loc>https://epicentre.msf.org/publications/three-drug-combinations-late-stage-trypanosoma-brucei-gambiense-sleeping-sickness</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/three-drug-combinations-late-stage-trypanosoma-brucei-gambiense-sleeping-sickness" /></url>
<url><loc>https://epicentre.msf.org/publications/operational-response-malaria-epidemics-are-rapid-diagnostic-tests-cost-effective</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/operational-response-malaria-epidemics-are-rapid-diagnostic-tests-cost-effective" /></url>
<url><loc>https://epicentre.msf.org/publications/comparison-cluster-and-systematic-sampling-methods-measuring-crude-mortality</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/comparison-cluster-and-systematic-sampling-methods-measuring-crude-mortality" /></url>
<url><loc>https://epicentre.msf.org/publications/artesunate-amodiaquine-and-artesunate-sulphadoxine-pyrimethamine-treatment</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/artesunate-amodiaquine-and-artesunate-sulphadoxine-pyrimethamine-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/evaluation-three-rapid-tests-diagnosis-p-falciparum-and-p-vivax-malaria-colombia</loc><lastmod>2019-02-18T15:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evaluation-three-rapid-tests-diagnosis-p-falciparum-and-p-vivax-malaria-colombia" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-three-artemisinin-combination-therapies-treatment-uncomplicated-plasmodium</loc><lastmod>2019-02-18T15:39Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-three-artemisinin-combination-therapies-treatment-uncomplicated-plasmodium" /></url>
<url><loc>https://epicentre.msf.org/publications/geographical-distribution-selected-and-putatively-neutral-snps-southeast-asian-malaria</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/geographical-distribution-selected-and-putatively-neutral-snps-southeast-asian-malaria" /></url>
<url><loc>https://epicentre.msf.org/publications/does-one-size-fit-all-drug-resistance-and-standard-treatments-results-six-tuberculosis</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/does-one-size-fit-all-drug-resistance-and-standard-treatments-results-six-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/diagnostic-accuracy-two-rk39-antigen-based-dipsticks-and-formol-gel-test-rapid</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/diagnostic-accuracy-two-rk39-antigen-based-dipsticks-and-formol-gel-test-rapid" /></url>
<url><loc>https://epicentre.msf.org/publications/evidence-basis-antimalarial-policy-change-sierra-leone-five-vivo-efficacy-studies</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/evidence-basis-antimalarial-policy-change-sierra-leone-five-vivo-efficacy-studies" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-and-effectiveness-combination-sulfadoxinepyrimethamine-and-3-day-course</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-and-effectiveness-combination-sulfadoxinepyrimethamine-and-3-day-course" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-and-malnutrition-among-populations-living-south-darfur-sudan-results-3</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-and-malnutrition-among-populations-living-south-darfur-sudan-results-3" /></url>
<url><loc>https://epicentre.msf.org/publications/control-mucocutaneous-leishmaniasis-neglected-disease-results-control-programme-satipo</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/control-mucocutaneous-leishmaniasis-neglected-disease-results-control-programme-satipo" /></url>
<url><loc>https://epicentre.msf.org/publications/south-asian-tsunami</loc><lastmod>2019-03-01T13:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/south-asian-tsunami" /></url>
<url><loc>https://epicentre.msf.org/publications/antimalarial-efficacy-chloroquine-amodiaquine-sulfadoxine-pyrimethamine-and</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antimalarial-efficacy-chloroquine-amodiaquine-sulfadoxine-pyrimethamine-and" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-nuba-mountains-sudan-baseline-genotypic-resistance-and-efficacy-artesunate</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-nuba-mountains-sudan-baseline-genotypic-resistance-and-efficacy-artesunate" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-mass-oral-cholera-vaccination-beira-mozambique</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-mass-oral-cholera-vaccination-beira-mozambique" /></url>
<url><loc>https://epicentre.msf.org/publications/selection-strength-and-hitchhiking-around-two-anti-malarial-resistance-genes</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/selection-strength-and-hitchhiking-around-two-anti-malarial-resistance-genes" /></url>
<url><loc>https://epicentre.msf.org/publications/ceftriaxone-effective-long-acting-chloramphenicol-short-course-treatment-meningococcal</loc><lastmod>2019-03-01T13:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ceftriaxone-effective-long-acting-chloramphenicol-short-course-treatment-meningococcal" /></url>
<url><loc>https://epicentre.msf.org/publications/genetic-heterogeneity-hepatitis-e-virus-darfur-sudan-and-neighboring-chad</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/genetic-heterogeneity-hepatitis-e-virus-darfur-sudan-and-neighboring-chad" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-options-visceral-leishmaniasis-systematic-review-clinical-studies-done-india</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-options-visceral-leishmaniasis-systematic-review-clinical-studies-done-india" /></url>
<url><loc>https://epicentre.msf.org/publications/cetyl-pyridinium-chloride-useful-isolation-mycobacterium-tuberculosis-sputa-subjected</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cetyl-pyridinium-chloride-useful-isolation-mycobacterium-tuberculosis-sputa-subjected" /></url>
<url><loc>https://epicentre.msf.org/publications/supervised-versus-unsupervised-intake-six-dose-artemether-lumefantrine-treatment-acute</loc><lastmod>2019-03-01T13:22Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/supervised-versus-unsupervised-intake-six-dose-artemether-lumefantrine-treatment-acute" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-two-artemisinin-combination-therapies-uncomplicated-falciparum-malaria</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-two-artemisinin-combination-therapies-uncomplicated-falciparum-malaria" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-chloroquine-sulfadoxine-pyrimethamine-mefloquine-artesunate-and-artemether</loc><lastmod>2019-02-18T15:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-chloroquine-sulfadoxine-pyrimethamine-mefloquine-artesunate-and-artemether" /></url>
<url><loc>https://epicentre.msf.org/publications/artesunate-combinations-treatment-malaria-meta-analysis</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/artesunate-combinations-treatment-malaria-meta-analysis" /></url>
<url><loc>https://epicentre.msf.org/publications/simplifying-and-adapting-antiretroviral-treatment-resource-poor-settings-necessary</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/simplifying-and-adapting-antiretroviral-treatment-resource-poor-settings-necessary" /></url>
<url><loc>https://epicentre.msf.org/publications/antimalarial-efficacy-sulfadoxine-pyrimethamine-amodiaquine-and-combination</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antimalarial-efficacy-sulfadoxine-pyrimethamine-amodiaquine-and-combination" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-west-nile-virus-causing-severe-neurological-involvement-children-nuba</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-west-nile-virus-causing-severe-neurological-involvement-children-nuba" /></url>
<url><loc>https://epicentre.msf.org/publications/adherence-combination-sulphadoxine-pyrimethamine-and-artesunate-maheba-refugee</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adherence-combination-sulphadoxine-pyrimethamine-and-artesunate-maheba-refugee" /></url>
<url><loc>https://epicentre.msf.org/publications/adherence-combination-artemether-and-lumefantrine-coartem-kajo-keji-southern-sudan</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adherence-combination-artemether-and-lumefantrine-coartem-kajo-keji-southern-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/violence-and-mortality-west-darfur-sudan-2003-04-epidemiological-evidence-four-surveys</loc><lastmod>2019-03-01T13:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/violence-and-mortality-west-darfur-sudan-2003-04-epidemiological-evidence-four-surveys" /></url>
<url><loc>https://epicentre.msf.org/publications/adherence-six-dose-regimen-artemether-lumefantrine-treatment-uncomplicated-plasmodium</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adherence-six-dose-regimen-artemether-lumefantrine-treatment-uncomplicated-plasmodium" /></url>
<url><loc>https://epicentre.msf.org/publications/case-management-multidrug-resistant-shigella-dysenteriae-serotype-1-outbreak-crisis</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/case-management-multidrug-resistant-shigella-dysenteriae-serotype-1-outbreak-crisis" /></url>
<url><loc>https://epicentre.msf.org/publications/trypanosoma-brucei-gambiense-trypanosomiasis-terego-county-northern-uganda-1996-lot</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/trypanosoma-brucei-gambiense-trypanosomiasis-terego-county-northern-uganda-1996-lot" /></url>
<url><loc>https://epicentre.msf.org/publications/high-mortality-displaced-populations-northern-uganda</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-mortality-displaced-populations-northern-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-camps-internally-displaced-persons-uganda-evaluation-insecticide-treated</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-camps-internally-displaced-persons-uganda-evaluation-insecticide-treated" /></url>
<url><loc>https://epicentre.msf.org/publications/vivo-assessment-drug-efficacy-against-plasmodium-falciparum-malaria-duration-follow</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vivo-assessment-drug-efficacy-against-plasmodium-falciparum-malaria-duration-follow" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-chloroquine-sulphadoxine-pyrimethamine-and-amodiaquine-treatment</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-chloroquine-sulphadoxine-pyrimethamine-and-amodiaquine-treatment" /></url>
<url><loc>https://epicentre.msf.org/publications/indirect-markers-initiate-highly-active-antiretroviral-therapy-rural-african-setting</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/indirect-markers-initiate-highly-active-antiretroviral-therapy-rural-african-setting" /></url>
<url><loc>https://epicentre.msf.org/publications/drug-resistance-plasmodium-falciparum-chittagong-hill-tracts-bangladesh</loc><lastmod>2019-02-18T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/drug-resistance-plasmodium-falciparum-chittagong-hill-tracts-bangladesh" /></url>
<url><loc>https://epicentre.msf.org/publications/consequences-armed-conflict-ethnic-karen-population</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/consequences-armed-conflict-ethnic-karen-population" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-among-displaced-former-unita-members-and-their-families-angola-retrospective</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-among-displaced-former-unita-members-and-their-families-angola-retrospective" /></url>
<url><loc>https://epicentre.msf.org/publications/shigella-dysenteriae-serotype-1-west-africa-intervention-strategy-outbreak-sierra</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/shigella-dysenteriae-serotype-1-west-africa-intervention-strategy-outbreak-sierra" /></url>
<url><loc>https://epicentre.msf.org/publications/large-cholera-outbreak-kano-city-nigeria-importance-hand-washing-soap-and-danger</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/large-cholera-outbreak-kano-city-nigeria-importance-hand-washing-soap-and-danger" /></url>
<url><loc>https://epicentre.msf.org/publications/assessing-efficacy-chloroquine-and-sulfadoxine-pyrimethamine-treatment-uncomplicated</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/assessing-efficacy-chloroquine-and-sulfadoxine-pyrimethamine-treatment-uncomplicated" /></url>
<url><loc>https://epicentre.msf.org/publications/neuro-inflammatory-risk-factors-treatment-failure-early-second-stage-sleeping-sickness</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/neuro-inflammatory-risk-factors-treatment-failure-early-second-stage-sleeping-sickness" /></url>
<url><loc>https://epicentre.msf.org/publications/intrathecal-immune-response-pattern-improved-diagnosis-central-nervous-system</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/intrathecal-immune-response-pattern-improved-diagnosis-central-nervous-system" /></url>
<url><loc>https://epicentre.msf.org/publications/selective-sweep-driven-pyrimethamine-treatment-southeast-asian-malaria-parasites</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/selective-sweep-driven-pyrimethamine-treatment-southeast-asian-malaria-parasites" /></url>
<url><loc>https://epicentre.msf.org/publications/artesunate-and-sulfadoxine-pyrimethamine-combinations-treatment-uncomplicated</loc><lastmod>2019-03-01T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/artesunate-and-sulfadoxine-pyrimethamine-combinations-treatment-uncomplicated" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-artesunate-plus-chloroquine-treatment-uncomplicated-malaria-children-burkina</loc><lastmod>2019-03-01T13:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-artesunate-plus-chloroquine-treatment-uncomplicated-malaria-children-burkina" /></url>
<url><loc>https://epicentre.msf.org/publications/highly-active-antiretroviral-therapy-resource-poor-settings-experience-medecins-sans</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/highly-active-antiretroviral-therapy-resource-poor-settings-experience-medecins-sans" /></url>
<url><loc>https://epicentre.msf.org/publications/systematic-screening-cryptococcal-antigenemia-hiv-positive-adults-uganda</loc><lastmod>2019-02-18T15:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/systematic-screening-cryptococcal-antigenemia-hiv-positive-adults-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-and-control-ebola-viral-haemorrhagic-fever-ugandan-medical-school</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-and-control-ebola-viral-haemorrhagic-fever-ugandan-medical-school" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-rift-valley-fever-northeastern-kenya-1997-98</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-rift-valley-fever-northeastern-kenya-1997-98" /></url>
<url><loc>https://epicentre.msf.org/publications/konzo-outbreak-south-west-democratic-republic-congo-1996</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/konzo-outbreak-south-west-democratic-republic-congo-1996" /></url>
<url><loc>https://epicentre.msf.org/publications/management-cholera-epidemics-refugee-camp</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/management-cholera-epidemics-refugee-camp" /></url>
<url><loc>https://epicentre.msf.org/publications/violence-southern-sudan</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/violence-southern-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/high-plasmodium-falciparum-resistance-chloroquine-and-sulfadoxine-pyrimethamine-harper</loc><lastmod>2019-03-01T13:11Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-plasmodium-falciparum-resistance-chloroquine-and-sulfadoxine-pyrimethamine-harper" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-amodiaquine-uncomplicated-plasmodium-falciparum-malaria-harper-liberia</loc><lastmod>2019-03-01T13:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-amodiaquine-uncomplicated-plasmodium-falciparum-malaria-harper-liberia" /></url>
<url><loc>https://epicentre.msf.org/publications/vitro-susceptibility-120-strains-neisseria-gonorrhoeae-isolated-kyrghyzstan</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vitro-susceptibility-120-strains-neisseria-gonorrhoeae-isolated-kyrghyzstan" /></url>
<url><loc>https://epicentre.msf.org/publications/visceral-leishmaniasis-current-status-control-diagnosis-and-treatment-and-proposed</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/visceral-leishmaniasis-current-status-control-diagnosis-and-treatment-and-proposed" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-current-status-control-diagnosis-treatment-and-proposed-agenda-research-and</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-current-status-control-diagnosis-treatment-and-proposed-agenda-research-and" /></url>
<url><loc>https://epicentre.msf.org/publications/validity-reliability-and-ease-use-field-five-rapid-tests-diagnosis-plasmodium</loc><lastmod>2019-03-01T13:02Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/validity-reliability-and-ease-use-field-five-rapid-tests-diagnosis-plasmodium" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-chloroquine-treatment-acute-uncomplicated-plasmodium-falciparum-malaria-laos</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-chloroquine-treatment-acute-uncomplicated-plasmodium-falciparum-malaria-laos" /></url>
<url><loc>https://epicentre.msf.org/publications/highly-active-antiretroviral-therapy-enhances-regression-cervical-intraepithelial</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/highly-active-antiretroviral-therapy-enhances-regression-cervical-intraepithelial" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-human-african-trypanosomiasis-present-situation-and-needs-research-and</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-human-african-trypanosomiasis-present-situation-and-needs-research-and" /></url>
<url><loc>https://epicentre.msf.org/publications/clinical-efficacy-chloroquine-or-sulfadoxine-pyrimethamine-children-under-five-south</loc><lastmod>2019-03-01T13:00Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/clinical-efficacy-chloroquine-or-sulfadoxine-pyrimethamine-children-under-five-south" /></url>
<url><loc>https://epicentre.msf.org/publications/igm-quantification-cerebrospinal-fluid-sleeping-sickness-patients-latex-card</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/igm-quantification-cerebrospinal-fluid-sleeping-sickness-patients-latex-card" /></url>
<url><loc>https://epicentre.msf.org/publications/interleukin-il-6-il-8-and-il-10-serum-and-csf-trypanosoma-brucei-gambiense-sleeping</loc><lastmod>2019-03-01T12:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/interleukin-il-6-il-8-and-il-10-serum-and-csf-trypanosoma-brucei-gambiense-sleeping" /></url>
<url><loc>https://epicentre.msf.org/publications/rapid-assessment-mortality-and-malnutrition-afghanistan</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/rapid-assessment-mortality-and-malnutrition-afghanistan" /></url>
<url><loc>https://epicentre.msf.org/publications/impact-war-civilian-population-health-republic-congo-december-1998-february-2000</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/impact-war-civilian-population-health-republic-congo-december-1998-february-2000" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-clinically-defined-pertussis-democratic-republic-congo</loc><lastmod>2019-02-18T15:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-clinically-defined-pertussis-democratic-republic-congo" /></url>
<url><loc>https://epicentre.msf.org/publications/rapid-assessment-population-size-area-sampling-disaster-situations</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/rapid-assessment-population-size-area-sampling-disaster-situations" /></url>
<url><loc>https://epicentre.msf.org/publications/availability-and-affordability-treatment-human-african-trypanosomiasis</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/availability-and-affordability-treatment-human-african-trypanosomiasis" /></url>
<url><loc>https://epicentre.msf.org/publications/documenting-violence-against-refugees</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/documenting-violence-against-refugees" /></url>
<url><loc>https://epicentre.msf.org/publications/biological-data-and-clinical-symptoms-predictors-astrogliosis-and-neurodegeneration</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/biological-data-and-clinical-symptoms-predictors-astrogliosis-and-neurodegeneration" /></url>
<url><loc>https://epicentre.msf.org/publications/detection-meningococcal-meningitis-epidemics-africa-new-recommendation</loc><lastmod>2019-03-01T12:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detection-meningococcal-meningitis-epidemics-africa-new-recommendation" /></url>
<url><loc>https://epicentre.msf.org/publications/timely-detection-meningococcal-meningitis-epidemics-africa</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/timely-detection-meningococcal-meningitis-epidemics-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/melarsoprol-refractory-t-b-gambiense-omugo-north-western-uganda</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/melarsoprol-refractory-t-b-gambiense-omugo-north-western-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/shortage-vaccines-during-yellow-fever-outbreak-guinea</loc><lastmod>2019-03-01T12:54Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/shortage-vaccines-during-yellow-fever-outbreak-guinea" /></url>
<url><loc>https://epicentre.msf.org/publications/human-african-trypanosomiasis-history-its-therapies-and-their-failures</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/human-african-trypanosomiasis-history-its-therapies-and-their-failures" /></url>
<url><loc>https://epicentre.msf.org/publications/short-communication-lassa-fever-sierra-leone-un-peacekeepers-are-risk</loc><lastmod>2019-02-18T15:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/short-communication-lassa-fever-sierra-leone-un-peacekeepers-are-risk" /></url>
<url><loc>https://epicentre.msf.org/publications/anthropometric-indices-used-diagnosis-malnutrition-adolescents-and-adults-review</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/anthropometric-indices-used-diagnosis-malnutrition-adolescents-and-adults-review" /></url>
<url><loc>https://epicentre.msf.org/publications/sleeping-sickness-danger-indifference</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/sleeping-sickness-danger-indifference" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-incidence-thresholds-detection-and-control-meningococcal-meningitis</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-incidence-thresholds-detection-and-control-meningococcal-meningitis" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemiology-cholera-outbreak-kampala-uganda</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemiology-cholera-outbreak-kampala-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/control-meningococcal-disease-west-africa</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/control-meningococcal-disease-west-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/detecting-meningococcal-meningitis-epidemics-highly-endemic-african-countries</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detecting-meningococcal-meningitis-epidemics-highly-endemic-african-countries" /></url>
<url><loc>https://epicentre.msf.org/publications/health-and-war-congo-brazzaville</loc><lastmod>2019-02-18T15:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/health-and-war-congo-brazzaville" /></url>
<url><loc>https://epicentre.msf.org/publications/famine-southern-sudan</loc><lastmod>2019-02-18T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/famine-southern-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/effectiveness-mass-vaccination-wcrbs-cholera-vaccine-during-epidemic-adjumani-district</loc><lastmod>2019-02-18T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/effectiveness-mass-vaccination-wcrbs-cholera-vaccine-during-epidemic-adjumani-district" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-death-hospitalized-dysentery-patients-rwanda</loc><lastmod>2019-02-18T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-death-hospitalized-dysentery-patients-rwanda" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-treatment-failure-after-melarsoprol-trypanosoma-brucei-gambiense</loc><lastmod>2019-03-01T12:53Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-treatment-failure-after-melarsoprol-trypanosoma-brucei-gambiense" /></url>
<url><loc>https://epicentre.msf.org/publications/mass-vaccination-two-dose-oral-cholera-vaccine-refugee-camp</loc><lastmod>2019-02-18T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mass-vaccination-two-dose-oral-cholera-vaccine-refugee-camp" /></url>
<url><loc>https://epicentre.msf.org/publications/therapeutic-failure-melarsoprol-among-patients-treated-late-stage-tb-gambiense-human</loc><lastmod>2019-02-18T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/therapeutic-failure-melarsoprol-among-patients-treated-late-stage-tb-gambiense-human" /></url>
<url><loc>https://epicentre.msf.org/publications/vaccination-emergencies</loc><lastmod>2019-02-18T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vaccination-emergencies" /></url>
<url><loc>https://epicentre.msf.org/publications/multifocal-outbreak-trichinellosis-linked-horse-meat-imported-north-america-france</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/multifocal-outbreak-trichinellosis-linked-horse-meat-imported-north-america-france" /></url>
<url><loc>https://epicentre.msf.org/publications/key-indicators-monitoring-and-evaluation-control-programmes-human-african</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/key-indicators-monitoring-and-evaluation-control-programmes-human-african" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemic-malaria-north-eastern-kenya</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemic-malaria-north-eastern-kenya" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-vaccine-effectiveness-standard-and-early-immunization-strategies-niger-1995</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-vaccine-effectiveness-standard-and-early-immunization-strategies-niger-1995" /></url>
<url><loc>https://epicentre.msf.org/publications/ciprofloxacin-treatment-dysentery-caused-type-1-shigella-dysenteriae-during-epidemic</loc><lastmod>2019-03-01T12:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/ciprofloxacin-treatment-dysentery-caused-type-1-shigella-dysenteriae-during-epidemic" /></url>
<url><loc>https://epicentre.msf.org/publications/antibiotic-sensitivity-endemic-shigella-mbarara-uganda</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/antibiotic-sensitivity-endemic-shigella-mbarara-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/long-acting-oily-chloramphenicol-meningococcal-meningitis</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/long-acting-oily-chloramphenicol-meningococcal-meningitis" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-and-vaccination-strategies-control-cholera-sub-saharan-refugee-settings-cost</loc><lastmod>2019-02-18T15:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-and-vaccination-strategies-control-cholera-sub-saharan-refugee-settings-cost" /></url>
<url><loc>https://epicentre.msf.org/publications/detection-trypanosomes-blood-quantitative-buffy-coat-qbc-technique-experimental</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/detection-trypanosomes-blood-quantitative-buffy-coat-qbc-technique-experimental" /></url>
<url><loc>https://epicentre.msf.org/publications/human-monkeypox-kasai-oriental-democratic-republic-congo-former-zaire-preliminary</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/human-monkeypox-kasai-oriental-democratic-republic-congo-former-zaire-preliminary" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemic-meningococcal-meningitis-region-savanes-togo-1997-research-and-control</loc><lastmod>2019-03-01T12:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemic-meningococcal-meningitis-region-savanes-togo-1997-research-and-control" /></url>
<url><loc>https://epicentre.msf.org/publications/cholera-outbreak-during-massive-influx-rwandan-returnees-november-1996</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/cholera-outbreak-during-massive-influx-rwandan-returnees-november-1996" /></url>
<url><loc>https://epicentre.msf.org/publications/meningococcal-vaccine-sub-saharan-africa</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/meningococcal-vaccine-sub-saharan-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/human-monkeypox-kasai-oriental-zaire-1996-1997</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/human-monkeypox-kasai-oriental-zaire-1996-1997" /></url>
<url><loc>https://epicentre.msf.org/publications/demographic-and-nutritional-consequences-civil-war-liberia</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/demographic-and-nutritional-consequences-civil-war-liberia" /></url>
<url><loc>https://epicentre.msf.org/publications/health-situation-refugees-eastern-zaire</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/health-situation-refugees-eastern-zaire" /></url>
<url><loc>https://epicentre.msf.org/publications/acts-violence-against-rwandan-refugees</loc><lastmod>2019-02-18T15:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/acts-violence-against-rwandan-refugees" /></url>
<url><loc>https://epicentre.msf.org/publications/meningitis-outbreaks-and-vaccination-strategy</loc><lastmod>2019-03-01T12:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/meningitis-outbreaks-and-vaccination-strategy" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemics-serogroup-neisseria-meningitidis-subgroup-iii-africa-1989-94</loc><lastmod>2019-02-18T15:54Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemics-serogroup-neisseria-meningitidis-subgroup-iii-africa-1989-94" /></url>
<url><loc>https://epicentre.msf.org/publications/public-health-impact-rwandan-refugee-crisis-what-happened-goma-zaire-july-1994-goma</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/public-health-impact-rwandan-refugee-crisis-what-happened-goma-zaire-july-1994-goma" /></url>
<url><loc>https://epicentre.msf.org/publications/2-epidemics-arsenical-encephalopathy-treatment-trypanosomiasis-uganda-1992-1993</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/2-epidemics-arsenical-encephalopathy-treatment-trypanosomiasis-uganda-1992-1993" /></url>
<url><loc>https://epicentre.msf.org/publications/recent-news-trichinellosis-another-outbreak-due-horsemeat-consumption-france-1993</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/recent-news-trichinellosis-another-outbreak-due-horsemeat-consumption-france-1993" /></url>
<url><loc>https://epicentre.msf.org/publications/malnutrition-displaced-persons-zaire</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malnutrition-displaced-persons-zaire" /></url>
<url><loc>https://epicentre.msf.org/publications/permethrin-impregnated-bed-nets-prevention-malaria-schoolchildren-thai-burmese-border</loc><lastmod>2019-03-01T12:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/permethrin-impregnated-bed-nets-prevention-malaria-schoolchildren-thai-burmese-border" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-epidemic-urban-community-niamey-transmission-patterns-vaccine-efficacy-and</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-epidemic-urban-community-niamey-transmission-patterns-vaccine-efficacy-and" /></url>
<url><loc>https://epicentre.msf.org/publications/vaccinal-efficacy-measures-and-methodological-constraints</loc><lastmod>2019-03-01T12:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/vaccinal-efficacy-measures-and-methodological-constraints" /></url>
<url><loc>https://epicentre.msf.org/publications/health-status-displaced-persons-following-civil-war-burundi-december-1993-january-1994</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/health-status-displaced-persons-following-civil-war-burundi-december-1993-january-1994" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-and-malnutrition-among-rwandan-refugees-zaire</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-and-malnutrition-among-rwandan-refugees-zaire" /></url>
<url><loc>https://epicentre.msf.org/publications/long-acting-chloramphenicol-versus-intravenous-ampicillin-treatment-bacterial</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/long-acting-chloramphenicol-versus-intravenous-ampicillin-treatment-bacterial" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-diphtheria-republic-georgia</loc><lastmod>2019-02-18T15:55Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-diphtheria-republic-georgia" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemiological-and-control-aspects-meningococcal-meningitis-epidemics-africa</loc><lastmod>2019-03-01T12:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemiological-and-control-aspects-meningococcal-meningitis-epidemics-africa" /></url>
<url><loc>https://epicentre.msf.org/publications/urinary-metabolites-niacin-during-course-pellagra</loc><lastmod>2019-02-18T15:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/urinary-metabolites-niacin-during-course-pellagra" /></url>
<url><loc>https://epicentre.msf.org/publications/public-health-consequences-civil-war-somalia-april-1992</loc><lastmod>2019-02-18T15:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/public-health-consequences-civil-war-somalia-april-1992" /></url>
<url><loc>https://epicentre.msf.org/publications/persistence-antibodies-trypanosoma-brucei-gambiense-after-treatment-human</loc><lastmod>2019-02-18T15:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/persistence-antibodies-trypanosoma-brucei-gambiense-after-treatment-human" /></url>
<url><loc>https://epicentre.msf.org/publications/efficacy-therapeutic-feeding-centre-evaluated-during-hospitalization-and-follow-period</loc><lastmod>2019-02-18T15:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/efficacy-therapeutic-feeding-centre-evaluated-during-hospitalization-and-follow-period" /></url>
<url><loc>https://epicentre.msf.org/publications/micronutrient-deficiencies-refugees</loc><lastmod>2019-02-18T15:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/micronutrient-deficiencies-refugees" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-surveillance-among-displaced-karen-population-thailand-april-1984-february</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-surveillance-among-displaced-karen-population-thailand-april-1984-february" /></url>
<url><loc>https://epicentre.msf.org/publications/centers-disease-control-public-health-consequences-acute-displacement-iraqi-citizens</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/centers-disease-control-public-health-consequences-acute-displacement-iraqi-citizens" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-pellagra-among-mozambican-refugees-malawi-1990</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-pellagra-among-mozambican-refugees-malawi-1990" /></url>
<url><loc>https://epicentre.msf.org/publications/practical-field-epidemiology-investigate-cholera-outbreak-mozambican-refugee-camp</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/practical-field-epidemiology-investigate-cholera-outbreak-mozambican-refugee-camp" /></url>
<url><loc>https://epicentre.msf.org/publications/malaria-during-pregnancy-area-unstable-endemicity</loc><lastmod>2019-03-01T12:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/malaria-during-pregnancy-area-unstable-endemicity" /></url>
<url><loc>https://epicentre.msf.org/publications/visceral-leishmaniasis-southern-sudan</loc><lastmod>2019-03-01T12:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/visceral-leishmaniasis-southern-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-factors-malnutrition-0-59-month-old-infants-2-districts-niger</loc><lastmod>2019-03-01T12:38Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-factors-malnutrition-0-59-month-old-infants-2-districts-niger" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-trends-among-refugees-honduras-1984-1987</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-trends-among-refugees-honduras-1984-1987" /></url>
<url><loc>https://epicentre.msf.org/publications/pellagra-mozambican-refugees</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/pellagra-mozambican-refugees" /></url>
<url><loc>https://epicentre.msf.org/publications/measles-outbreaks-mozambican-refugee-camps-malawi-continued-need-effective-vaccine</loc><lastmod>2019-02-18T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/measles-outbreaks-mozambican-refugee-camps-malawi-continued-need-effective-vaccine" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemiological-patterns-scurvy-among-ethiopian-refugees</loc><lastmod>2019-02-18T15:58Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemiological-patterns-scurvy-among-ethiopian-refugees" /></url>
<url><loc>https://epicentre.msf.org/publications/epidemic-visceral-leishmaniasis-southern-sudan</loc><lastmod>2019-02-18T15:58Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/epidemic-visceral-leishmaniasis-southern-sudan" /></url>
<url><loc>https://epicentre.msf.org/publications/clinical-presentation-louse-borne-relapsing-fever-among-ethiopian-refugees-northern</loc><lastmod>2019-02-18T15:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/clinical-presentation-louse-borne-relapsing-fever-among-ethiopian-refugees-northern" /></url>
<url><loc>https://epicentre.msf.org/publications/clinical-microbiological-and-antibiotic-susceptibility-patterns-diarrhoea-korem</loc><lastmod>2019-02-18T15:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/clinical-microbiological-and-antibiotic-susceptibility-patterns-diarrhoea-korem" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-heliotrope-food-poisoning-tadjikistan-november-1992-march-1993</loc><lastmod>2019-03-01T12:33Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-heliotrope-food-poisoning-tadjikistan-november-1992-march-1993" /></url>
<url><loc>https://epicentre.msf.org/publications/outbreak-pellagra-related-changes-dietary-niacin-among-mozambican-refugees-malawi</loc><lastmod>2019-02-18T15:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/outbreak-pellagra-related-changes-dietary-niacin-among-mozambican-refugees-malawi" /></url>
<url><loc>https://epicentre.msf.org/publications/viral-hepatitis-bucharest</loc><lastmod>2019-02-18T15:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/viral-hepatitis-bucharest" /></url>
<url><loc>https://epicentre.msf.org/publications/aetiology-haemorrhagic-colitis-epidemic-africa</loc><lastmod>2019-02-18T15:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/aetiology-haemorrhagic-colitis-epidemic-africa" /></url>
<url><loc>https://epicentre.msf.org/actualites/lancement-dune-nouvelle-etude-sur-le-traitement-de-premiere-ligne-de-linfection-vih-au</loc><lastmod>2019-04-12T06:40Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/new-hiv-first-line-treatment-study-launched-malawi" /></url>
<url><loc>https://epicentre.msf.org/rifavirenz-la-rifampicine-forte-dose-peut-elle-etre-une-option-pour-raccourcir-le-traitement-de-la</loc><lastmod>2019-02-22T10:53Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/rifavirenz-can-high-dose-rifampicin-be-option-shorten-tuberculosis-treatment-tuberculosis-and-hiv" /></url>
<url><loc>https://epicentre.msf.org/portfolio/la-tuberculose</loc><lastmod>2019-04-11T12:06Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/publications/adherence-tolerability-and-outcome-after-36-months-isoniazid-preventive-therapy-2</loc><lastmod>2019-02-22T11:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/adherence-tolerability-and-outcome-after-36-months-isoniazid-preventive-therapy-2" /></url>
<url><loc>https://epicentre.msf.org/publications/mortality-first-six-months-among-hiv-positive-and-hiv-negative-patients-empirically</loc><lastmod>2019-02-22T12:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/mortality-first-six-months-among-hiv-positive-and-hiv-negative-patients-empirically" /></url>
<url><loc>https://epicentre.msf.org/publications/assessing-performance-real-time-epidemic-forecasts-case-study-ebola-western-area</loc><lastmod>2019-02-22T12:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/assessing-performance-real-time-epidemic-forecasts-case-study-ebola-western-area" /></url>
<url><loc>https://epicentre.msf.org/publications/post-traumatic-osteomyelitis-middle-east-war-wounded-civilians-resistance-first-line</loc><lastmod>2019-02-22T12:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/post-traumatic-osteomyelitis-middle-east-war-wounded-civilians-resistance-first-line" /></url>
<url><loc>https://epicentre.msf.org/publications/i-saw-it-second-chance-qualitative-exploration-experiences-treatment-failure-and</loc><lastmod>2019-02-22T12:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/i-saw-it-second-chance-qualitative-exploration-experiences-treatment-failure-and" /></url>
<url><loc>https://epicentre.msf.org/publications/genomic-insights-2016-2017-cholera-epidemic-yemen</loc><lastmod>2019-02-22T12:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/genomic-insights-2016-2017-cholera-epidemic-yemen" /></url>
<url><loc>https://epicentre.msf.org/portfolio/antibioresistance</loc><lastmod>2019-04-11T10:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/antibiotic-resistance" /></url>
<url><loc>https://epicentre.msf.org/actualites/reponse-aux-urgences-et-formation-en-epidemiologie-manille-philippines</loc><lastmod>2019-04-15T07:08Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/response-emergencies-and-epidemics-training-manila-philippines" /></url>
<url><loc>https://epicentre.msf.org/publications/incidence-switching-second-line-antiretroviral-therapy-and-associated-factors-children</loc><lastmod>2019-02-22T17:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/incidence-switching-second-line-antiretroviral-therapy-and-associated-factors-children" /></url>
<url><loc>https://epicentre.msf.org/cohorte-denfants-les-pieges-du-diagnostic-de-la-tuberculose-infantile-dans-les-pays-forte-charge-de</loc><lastmod>2019-02-26T16:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/kids-cohort-pitfalls-childhood-tuberculosis-diagnosis-high-burden-and-limited-resource-countries" /></url>
<url><loc>https://epicentre.msf.org/tb-speed-amelioration-du-diagnostic-de-la-tuberculose-infantile-laide-des-nouvelles-technologies</loc><lastmod>2019-02-26T16:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/tb-speed-improvement-childhood-tuberculosis-diagnosis-using-new-technologies-use-low-level-health" /></url>
<url><loc>https://epicentre.msf.org/nigeria-crise-de-bono-mortalite-et-malnutrition-dans-les-zones-dintervention-de-msf-masson-s</loc><lastmod>2019-02-26T17:04Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/nigeria-bono-crisis-mortality-and-malnutrition-areas-msf-intervention-masson-s-abstract-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/portage-du-pneumocoque-avant-et-apres-le-vaccin-pneumocoque-conjugue-vpc-dans-le-camp-de-refugies</loc><lastmod>2019-02-26T17:06Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/pneumococcal-carriage-pre-and-post-pcv-vaccination-campaign-adjumani-refugee-camp-uganda-nyehangane" /></url>
<url><loc>https://epicentre.msf.org/lassociation-dihydroartemisininepiperaquine-comme-traitement-preventif-intermittent-pour-les</loc><lastmod>2019-02-26T17:10Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/dihydroartemisinin-piperaquine-intermittent-preventive-treatment-children-refugee-camp-coldiron-m" /></url>
<url><loc>https://epicentre.msf.org/evaluation-et-surveillance-de-la-sante-dans-les-camps-de-refugies-du-nord-de-louganda-ardiet-d</loc><lastmod>2019-02-26T17:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/health-assessment-and-surveillance-refugee-camps-northern-uganda-ardiet-d-abstract-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/vaccins-oraux-contre-le-cholera-transformer-les-anciens-produits-en-solutions-nouvelles-pour-les</loc><lastmod>2019-02-26T17:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/oral-cholera-vaccines-transforming-old-products-new-solutions-neglected-populations-luquero-f-0" /></url>
<url><loc>https://epicentre.msf.org/psyca-developper-un-outil-pour-identifier-les-jeunes-enfants-presentant-des-problemes-de-sante</loc><lastmod>2019-02-26T17:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/psyca-developing-tool-identify-young-children-mental-health-problems-nackers-f-abstract-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/antivenins-et-morsures-de-serpents-la-recherche-pour-combattre-les-carences-du-marche-et-les</loc><lastmod>2019-03-03T15:31Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/antivenoms-snake-bites-combatting-market-failure-and-neglect-research-coldiron-m-abstract-uganda" /></url>
<url><loc>https://epicentre.msf.org/le-controle-des-infections-lere-de-la-resistance-aux-antibiotiques-langendorf-c-abstract-ouganda</loc><lastmod>2019-03-03T15:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/infection-control-era-antibiotic-resistance-langendorf-c-abstract-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/efficacite-et-innocuite-dun-nouveau-vaccin-antirotavirus-thermostable-rose-seck-am-abstract-ouganda</loc><lastmod>2019-02-27T13:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/efficacy-and-safety-new-heat-stable-rotavirus-vaccine-rose-seck-am-abstract-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/journees-scientifiques/journee-scientifique-2016</loc><lastmod>2019-03-18T11:55Z</lastmod><changefreq>never</changefreq><priority>0.6</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/scientific-days/scientific-day-2016" /></url>
<url><loc>https://epicentre.msf.org/actualites/la-reunion-vaincre-la-meningite-dici-2030</loc><lastmod>2019-04-12T05:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/meningitis-global-roadmap-meeting" /></url>
<url><loc>https://epicentre.msf.org/actualites/enquete-sur-la-couverture-vaccinale-contre-le-cholera-maradi-niger</loc><lastmod>2019-04-12T06:05Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/post-vaccination-coverage-survey-oral-cholera-vaccine-maradi-niger" /></url>
<url><loc>https://epicentre.msf.org/actualites/enquete-sur-les-indicateurs-de-sante-materno-infantile-district-sanitaire-de-moissala</loc><lastmod>2019-04-12T05:52Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/mother-and-child-health-indicators-survey-moissala-health-district-chad" /></url>
<url><loc>https://epicentre.msf.org/diagnostic-de-la-tuberculose-dans-un-contexte-de-prevalence-elevee-du-vih-huerga-h-abstract-2016-en</loc><lastmod>2019-03-09T10:11Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/diagnosing-tuberculosis-high-hiv-prevalence-setting-huerga-h-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/echec-virologique-resistance-au-traitement-et-besoins-en-regime-de-3eme-ligne-pour-les-patients</loc><lastmod>2019-03-09T10:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/virological-failure-drug-resistance-and-third-line-regimen-requirements-among-patients-receiving" /></url>
<url><loc>https://epicentre.msf.org/mise-en-place-de-la-mesure-de-la-charge-virale-par-methode-point-care-resultats-dun-programme-vih</loc><lastmod>2019-03-09T10:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/implementation-point-care-viral-load-testing-outcomes-decentralised-hiv-program-malawi-poulet-e" /></url>
<url><loc>https://epicentre.msf.org/strategies-innovantes-de-delivrance-du-vaccin-cholera-luquero-f-abstract-2016-en</loc><lastmod>2019-03-09T10:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/innovative-delivery-strategies-oral-cholera-vaccine-luquero-f-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/amelioration-des-tests-de-diagnostic-rapide-du-cholera-page-al-abstract-2016-en</loc><lastmod>2019-03-09T10:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/improving-performance-cholera-rapid-diagnostic-tests-page-al-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/place-de-la-doxycycline-dans-la-prevention-du-cholera-grandesso-f-abstract-2016-en</loc><lastmod>2019-03-09T10:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/use-doxycycline-prevent-cholera-grandesso-f-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/epidemie-de-syndrome-dystonique-en-ituri-rdc-rafael-f-abstract-2016</loc><lastmod>2019-03-09T10:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/outbreak-dystonic-syndrome-ituri-drc-rafael-f-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/intoxication-aigue-chez-des-enfants-monrovia-liberia-haidar-m-abstract-2016-en</loc><lastmod>2019-03-09T10:54Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/acute-intoxication-among-children-monrovia-liberia-haidar-m-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/traitement-des-morsures-de-serpent-dans-les-programmes-msf-coldiron-m-abstract-2016-en</loc><lastmod>2019-03-09T10:58Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/treatment-snakebites-msf-programs-coldiron-m-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/estimation-de-la-mortalite-parmi-des-populations-deplacees-au-sahel-toure-b-abstract-2016</loc><lastmod>2019-03-09T11:01Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/estimating-mortality-among-displaced-populations-sahel-toure-b-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/utilisation-des-methodes-epidemiologiques-dans-lestimation-des-besoins-des-migrants-en-france</loc><lastmod>2019-03-09T11:05Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/use-epidemiologic-methods-estimate-needs-among-migrants-france-bouhenia-m-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/developpement-dune-echelle-devaluation-en-sante-mentale-etude-de-validation-en-palestine-et-en</loc><lastmod>2019-03-09T11:08Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/developing-outcome-scale-mental-health-validation-study-palestine-and-colombia-llosa-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/efficacite-et-tolerance-dun-vaccin-contre-le-rotavirus-guindo-o-abstract-2016</loc><lastmod>2019-03-09T11:11Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/efficacy-and-safety-rotavirus-vaccine-guindo-o-abstract-2016" /></url>
<url><loc>https://epicentre.msf.org/acceptabilite-et-utilisation-dun-supplement-nutritionnel-base-de-lipides-en-quantite-moyenne</loc><lastmod>2019-03-09T15:54Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/acceptability-and-utilization-medium-quantity-lipid-based-nutrient-supplement-formulated-pregnant" /></url>
<url><loc>https://epicentre.msf.org/tuberculose-infantile-lhopital-national-de-reference-de-mbarara-ouganda-une-description-des</loc><lastmod>2019-03-09T16:25Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/childhood-tuberculosis-mbarara-national-referral-hospital-uganda-description-patients-and-diagnosis" /></url>
<url><loc>https://epicentre.msf.org/resultats-du-traitement-et-tolerabilite-des-doses-de-medicaments-antituberculeux-revisees-par-loms</loc><lastmod>2019-03-10T07:06Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/treatment-outcomes-and-tolerability-revised-who-antituberculous-drug-dosages-among-children-living" /></url>
<url><loc>https://epicentre.msf.org/description-de-la-cascade-de-la-charge-virale-des-patients-arv-en-utilisant-samba-une-methode-poc</loc><lastmod>2019-03-10T07:11Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/description-viral-load-cascade-art-patients-using-samba-point-care-viral-load-testing-method" /></url>
<url><loc>https://epicentre.msf.org/performance-des-algorithmes-de-diagnostic-du-vih-sur-6-sites-dans-5-pays-dafrique-subsaharienne</loc><lastmod>2019-03-10T07:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/performance-hiv-diagnostic-algorithms-6-sites-5-sub-saharan-african-countries-page-al-poster-2016" /></url>
<url><loc>https://epicentre.msf.org/precision-diagnostique-de-8-tdr-vih-et-de-2-tests-de-confirmation-simples-sur-des-echantillons</loc><lastmod>2019-03-10T07:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/diagnostic-accuracy-8-hiv-rdts-and-2-simple-confirmatory-assays-specimens-5-sub-saharan-african" /></url>
<url><loc>https://epicentre.msf.org/evaluation-de-la-delegation-de-taches-du-personnel-non-medical-forme-lutilisation-de-samba-une</loc><lastmod>2019-03-10T07:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/evaluation-task-shifting-samba-hiv-viral-load-point-care-testing-trained-non-health-workers-malawi" /></url>
<url><loc>https://epicentre.msf.org/letude-rapid-regional-anaesthesia-painful-injuries-after-disasters-un-protocole-dessai-controle-et</loc><lastmod>2019-03-10T08:53Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/regional-anaesthesia-painful-injuries-after-disasters-rapid-study-ran-domized-controlled-trial" /></url>
<url><loc>https://epicentre.msf.org/diagnostic-de-la-tuberculose-dans-un-contexte-de-prevalence-elevee-du-vih-huerga-h-video-2016-en</loc><lastmod>2019-03-10T11:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/diagnosing-tuberculosis-high-hiv-prevalence-setting-huerga-h-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/echec-virologique-resistance-au-traitement-et-besoins-en-regime-de-3eme-ligne-pour-les-patients-0</loc><lastmod>2019-03-10T12:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/virological-failure-drug-resistance-and-third-line-regimen-requirements-among-patients-receiving-0" /></url>
<url><loc>https://epicentre.msf.org/mise-en-place-de-la-mesure-de-la-charge-virale-par-methode-point-care-resultats-dun-programme-vih-0</loc><lastmod>2019-03-10T13:51Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/implementation-point-care-viral-load-testing-outcomes-decentralised-hiv-program-malawi-poulet-e-0" /></url>
<url><loc>https://epicentre.msf.org/strategies-innovantes-de-delivrance-du-vaccin-cholera-luquero-f-video-2016-en</loc><lastmod>2019-03-10T14:00Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/innovative-delivery-strategies-oral-cholera-vaccine-luquero-f-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/amelioration-des-tests-de-diagnostic-rapide-du-cholera-page-al-video-2016-en</loc><lastmod>2019-03-10T14:05Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/improving-performance-cholera-rapid-diagnostic-tests-page-al-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/place-de-la-doxycycline-dans-la-prevention-du-cholera-grandesso-f-video-2016-en</loc><lastmod>2019-03-10T14:10Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/use-doxycycline-prevent-cholera-grandesso-f-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/rougeole-en-rdc-lecons-des-epidemies-recentes-blake-video-2016-fr</loc><lastmod>2019-03-10T14:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/measles-drc-lessons-recent-epidemics-blake-video-2016-fr" /></url>
<url><loc>https://epicentre.msf.org/epidemie-de-syndrome-dystonique-en-ituri-rdc-rafael-f-video-2016-fr</loc><lastmod>2019-03-10T14:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/outbreak-dystonic-syndrome-ituri-drc-rafael-f-video-2016-fr" /></url>
<url><loc>https://epicentre.msf.org/intoxication-aigue-chez-des-enfants-monrovia-liberia-haidar-m-video-2016-en</loc><lastmod>2019-03-10T14:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/acute-intoxication-among-children-monrovia-liberia-haidar-m-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/nos-concretisations/vihsida</loc><lastmod>2019-04-11T13:01Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/our-achievements/hivaids" /></url>
<url><loc>https://epicentre.msf.org/traitement-des-morsures-de-serpent-dans-les-programmes-msf-coldiron-m-video-2016-en</loc><lastmod>2019-03-11T14:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/treatment-snakebites-msf-programs-coldiron-m-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/seroprevalence-debola-monrovia-liberia-gerstl-s-video-2016-en</loc><lastmod>2019-03-11T14:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/seroprevalence-ebola-monrovia-liberia-gerstl-s-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/estimation-de-la-mortalite-parmi-des-populations-deplacees-au-sahel-toure-b-video-2016-en</loc><lastmod>2019-03-11T14:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/estimating-mortality-among-displaced-populations-sahel-toure-b-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/utilisation-des-methodes-epidemiologiques-dans-lestimation-des-besoins-des-migrants-en-france-0</loc><lastmod>2019-03-11T14:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/use-epidemiologic-methods-estimate-needs-among-migrants-france-bouhenia-m-video-2016-fr" /></url>
<url><loc>https://epicentre.msf.org/developpement-dune-echelle-devaluation-en-sante-mentale-etude-de-validation-en-palestine-et-en-0</loc><lastmod>2019-03-11T14:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/developing-outcome-scale-mental-health-validation-study-palestine-and-colombia-llosa-video-2016-en" /></url>
<url><loc>https://epicentre.msf.org/efficacite-et-tolerance-dun-vaccin-contre-le-rotavirus-guindo-o-video-2016-fr</loc><lastmod>2019-03-11T14:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/efficacy-and-safety-rotavirus-vaccine-guindo-o-video-2016-fr" /></url>
<url><loc>https://epicentre.msf.org/surveillance-de-la-charge-virale-avec-samba-1-ougandaposterepicentre-msfias2017nicolas-s-en</loc><lastmod>2019-03-14T11:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/viral-load-monitoring-samba-1ugandaposterepicentre-msfias2017nicolas-s" /></url>
<url><loc>https://epicentre.msf.org/accroitre-lacces-la-charge-virale-de-routine-avec-samba-presque-au-point-de</loc><lastmod>2019-03-12T09:05Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/increasing-access-routine-viral-load-nearly-point-care-sambaposteraidsconf2016nicolas-s" /></url>
<url><loc>https://epicentre.msf.org/evaluation-transversale-de-lechec-virologique-resistance-et-traitement-3e-ligne-pour-patients-qui</loc><lastmod>2019-03-12T09:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cross-sectional-assessment-virological-failure-drug-resistance-and-third-line-regimen-requirements" /></url>
<url><loc>https://epicentre.msf.org/publications/analysis-meningococcal-meningitis-outbreak-niger-potential-effectiveness-reactive</loc><lastmod>2019-03-12T12:54Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/analysis-meningococcal-meningitis-outbreak-niger-potential-effectiveness-reactive" /></url>
<url><loc>https://epicentre.msf.org/bacteriemie-dans-un-hopital-pediatrique-au-niger-langendorf-c-abstract-2018-en</loc><lastmod>2019-01-17T13:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/bacterial-bloodstream-infections-pediatric-hospital-niger-langendorf-c-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/publications/publisher-correction-genomic-insights-2016-2017-cholera-epidemic-yemen</loc><lastmod>2019-03-25T16:08Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/publisher-correction-genomic-insights-2016-2017-cholera-epidemic-yemen" /></url>
<url><loc>https://epicentre.msf.org/publications/treatment-outcomes-patients-switching-injectable-drug-bedaquiline-during-short</loc><lastmod>2019-03-25T16:08Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/treatment-outcomes-patients-switching-injectable-drug-bedaquiline-during-short" /></url>
<url><loc>https://epicentre.msf.org/actualites/etude-sur-les-violences-sexuelles-basees-sur-le-genre-au-kenya</loc><lastmod>2019-04-12T05:06Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/sexual-and-gender-based-violence-support-study-kenya" /></url>
<url><loc>https://epicentre.msf.org/etude-sur-les-violences-sexuelles-basees-sur-le-genre-au-kenya-2019-en</loc><lastmod>2019-04-08T10:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/sexual-and-gender-based-violence-study-kenya-2019" /></url>
<url><loc>https://epicentre.msf.org/actualites/enquete-pour-mesurer-la-connaissance-du-statut-serologique-positif-de-linfection-vih</loc><lastmod>2019-04-19T14:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/survey-measure-hiv-positive-status-awareness-among-female-sex-workers-nsanje-malawi" /></url>
<url><loc>https://epicentre.msf.org/publications/risk-score-predicting-mortality-including-urine-lipoarabinomannan-detection-hospital</loc><lastmod>2019-04-15T16:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/risk-score-predicting-mortality-including-urine-lipoarabinomannan-detection-hospital" /></url>
<url><loc>https://epicentre.msf.org/publications/high-incidence-intended-partner-pregnancy-among-men-living-hiv-rural-uganda</loc><lastmod>2019-04-15T16:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/high-incidence-intended-partner-pregnancy-among-men-living-hiv-rural-uganda" /></url>
<url><loc>https://epicentre.msf.org/publications/screening-tool-psychological-difficulties-children-aged-6-36-months-cross-cultural</loc><lastmod>2019-04-15T16:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/screening-tool-psychological-difficulties-children-aged-6-36-months-cross-cultural" /></url>
<url><loc>https://epicentre.msf.org/publications/control-ebola-virus-disease-outbreaks-comparison-health-care-worker-targeted-and</loc><lastmod>2019-04-15T16:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/control-ebola-virus-disease-outbreaks-comparison-health-care-worker-targeted-and" /></url>
<url><loc>https://epicentre.msf.org/actualites/le-lancet-global-health-soutient-les-scientifiques-francophones</loc><lastmod>2019-04-19T11:04Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/lancet-global-health-support-francophone-scientists" /></url>
<url><loc>https://epicentre.msf.org/publications/plaidoyer-contre-lexclusion-des-francophones-dans-la-recherche-en-sante-mondiale</loc><lastmod>2019-04-19T11:00Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/publications/plaidoyer-contre-lexclusion-des-francophones-dans-la-recherche-en-sante-mondiale" /></url>
<url><loc>https://epicentre.msf.org/antibiotiques-de-routine-dans-le-traitement-de-la-malnutrition-aigue-severe-non-compliquee-au-0</loc><lastmod>2019-01-17T13:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/routine-antibiotics-treatment-uncomplicated-severe-acute-malnutrition-niger-chokote-b-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/actualites/journee-scientifique-2019</loc><lastmod>2019-03-12T08:47Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/scientific-day-2019" /></url>
<url><loc>https://epicentre.msf.org/apport-nutritionnel-chez-les-femmes-enceintes-au-niger-isanaka-s-abstract-2018-en</loc><lastmod>2019-01-17T13:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/nutritional-support-pregnant-women-niger-isanaka-s-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/journees-scientifiques/journee-scientifique-2018</loc><lastmod>2019-03-18T11:01Z</lastmod><changefreq>never</changefreq><priority>0.6</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/scientific-days/scientific-day-2018" /></url>
<url><loc>https://epicentre.msf.org/contact</loc><lastmod>2019-02-26T14:51Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/contact" /></url>
<url><loc>https://epicentre.msf.org/mentions-legales</loc><lastmod>2019-03-22T21:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/term-use" /></url>
<url><loc>https://epicentre.msf.org/presentation-depicentre-ouganda-video</loc><lastmod>2019-01-16T14:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/introducting-epicentre-uganda-video" /></url>
<url><loc>https://epicentre.msf.org/le-voyage-des-migrants-et-leurs-vulnerabilites-dans-les-camps-de-refugies-en-grece-rapport-2017-en</loc><lastmod>2019-02-05T13:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/migrants-journey-and-their-vulnerabilities-refugee-camps-greece-report-2017" /></url>
<url><loc>https://epicentre.msf.org/faible-prevalence-du-virus-de-lhepatite-c-parmi-les-patients-vivant-avec-le-vih-en-afrique-sub</loc><lastmod>2019-01-31T14:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/low-hcv-prevalence-among-hiv-individuals-sub-saharan-africa-loarec-poster-2017" /></url>
<url><loc>https://epicentre.msf.org/cameroun-le-corps-medical-gangrene-par-lhepatite-b</loc><lastmod>2019-02-05T13:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cameroon-medical-profession-exposed-hepatitis-b-fr" /></url>
<url><loc>https://epicentre.msf.org/portfolio/les-morsures-de-serpent</loc><lastmod>2019-04-11T12:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/snakebite" /></url>
<url><loc>https://epicentre.msf.org/brochure-epicentre</loc><lastmod>2019-02-21T16:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/brochure-epicentre" /></url>
<url><loc>https://epicentre.msf.org/brochure-epicentre-niger</loc><lastmod>2019-02-05T13:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/brochure-epicentre-niger" /></url>
<url><loc>https://epicentre.msf.org/epicentre/la-formation</loc><lastmod>2019-04-08T10:03Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/training" /></url>
<url><loc>https://epicentre.msf.org/actualites/bonne-annee-2019</loc><lastmod>2019-03-05T13:50Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/happy-new-year" /></url>
<url><loc>https://epicentre.msf.org/la-conversion-des-cultures-et-les-resultats-dun-traitement-de-courte-duree-contre-la-tuberculose</loc><lastmod>2019-01-17T13:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/culture-conversion-and-treatment-outcomes-short-treatment-regimen-multidrug-resistant-tuberculosis" /></url>
<url><loc>https://epicentre.msf.org/discerner-la-dynamique-des-infections-lhepatite-e-dans-les-populations-deplacees-implications-pour</loc><lastmod>2019-01-17T13:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/unravelling-dynamics-hepatitis-e-infections-displaced-populations-implications-reactive-vaccination" /></url>
<url><loc>https://epicentre.msf.org/prevalence-de-la-parasitemie-dans-une-zone-de-chimio-prevention-saisonniere-du-paludisme-coldiron-m</loc><lastmod>2019-01-17T14:00Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/prevalence-parasitemia-area-receiving-seasonal-malaria-chemoprevention-coldiron-m-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/efficacite-protectrice-de-la-chimio-prevention-du-paludisme-saisonnier-magaria-niger-coldiron-m</loc><lastmod>2019-01-17T14:08Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/protective-effectiveness-seasonal-malaria-chemoprevention-magaria-niger-coldiron-m-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/la-prophylaxie-par-ciprofloxacine-dose-unique-administree-par-voie-orale-en-reponse-une-epidemie-de</loc><lastmod>2019-01-17T14:56Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/single-dose-oral-ciprofloxacin-prophylaxis-meningococcal-meningitis-outbreak-response-results" /></url>
<url><loc>https://epicentre.msf.org/defis-sur-le-terrain-pour-lelimination-de-la-rougeole-en-republique-democratique-du-congo-coulbourn</loc><lastmod>2019-01-17T15:10Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/field-challenges-measles-elimination-democratic-republic-congo-coulbourn-r-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/reduire-la-frequence-du-suivi-et-du-partage-des-taches-dans-le-traitement-de-la-mas-non-compliquee</loc><lastmod>2019-01-17T15:42Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/reducing-frequency-follow-and-task-sharing-treatment-uncomplicated-sam-evaluation-access-limited" /></url>
<url><loc>https://epicentre.msf.org/infections-bacteriennes-invasives-dorigine-communautaire-et-hospitaliere-chez-lenfant-au-mali</loc><lastmod>2019-01-17T15:49Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/community-and-hospital-acquired-invasive-bacterial-infections-children-mali-aetiology-antibiotic" /></url>
<url><loc>https://epicentre.msf.org/charge-des-maladies-du-cholera-et-circulation-des-souches-de-v-cholerae-en-afrique-luquero-f-poster</loc><lastmod>2019-01-17T15:57Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cholera-diseases-burden-and-circulation-v-cholerae-strains-africa-luquero-f-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/le-regroupement-spatial-du-cholera-et-ciblage-des-zones-affectees-luquero-f-poster-2018-en</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cholera-spatial-clustering-and-use-case-area-targeted-interventions-luquero-f-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/protection-par-le-vaccin-contre-le-cholera-une-meta-analyse-des-etudes-defficacite-et-efficience</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cholera-vaccine-protection-meta-analysis-efficacy-and-effectiveness-studies-luquero-f-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/transport-et-distribution-des-serotypes-de-pneumocoques-avant-et-apres-la-campagne-de-vaccination</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/pneumococcal-carriage-and-serotypes-distribution-pre-and-post-pcv10-vaccination-campaign-adjumani" /></url>
<url><loc>https://epicentre.msf.org/evaluation-du-vaccin-antirougeoleux-dans-des-conditions-de-temperature-controlee-prolongee-tang-k</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/evaluation-measles-vaccine-extended-controlled-temperature-conditions-tang-k-poster-2018" /></url>
<url><loc>https://epicentre.msf.org/enquete-de-mortalite-retrospective-zones-de-sante-de-tshibala-et-kalomba-kasai-central-republique</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/retrospective-mortality-survey-tshibala-and-kalomba-health-zones-kasai-central-democratic-republic" /></url>
<url><loc>https://epicentre.msf.org/prevalence-et-acces-aux-soins-conan-n-video-2017-en</loc><lastmod>2019-02-07T12:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/prevalence-and-linkage-care-conan-n-video-2017-en" /></url>
<url><loc>https://epicentre.msf.org/comprendre-lechec-virologique-chez-les-adolescents-vivant-avec-le-vih-dans-le-district-de</loc><lastmod>2019-02-08T07:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/understanding-virological-failure-adolescents-living-hiv-chiradzulu-district-malawi-evidence-cross" /></url>
<url><loc>https://epicentre.msf.org/diagnostic-precoce-du-jeune-enfant-realites-et-enjeux-maman-d-video-2017-en</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/early-infant-diagnosis-field-practices-and-challenges-maman-d-video-2017-en" /></url>
<url><loc>https://epicentre.msf.org/controle-des-infections-prescrire-sans-nuire-lere-de-lantibioresistance-langendorf-c-video-2017-fr</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/infection-control-prescribe-while-doing-no-harm-era-antibiotic-resistance-langendorf-c-video-2017" /></url>
<url><loc>https://epicentre.msf.org/quand-et-comment-changer-de-strategie-dans-une-epidemie-de-paludisme-aweil-soudan-du-sud-2016</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/when-and-how-change-strategy-malaria-epidemic-aweil-south-sudan-2016-nadimpalli-video-2017-en" /></url>
<url><loc>https://epicentre.msf.org/chimioprevention-du-paludisme-saisonnier-histoire-justification-et-enjeux-coldiron-m-video-2017-en</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/seasonal-malaria-chemoprevention-history-rationale-and-challenges-coldiron-m-video-2017-en" /></url>
<url><loc>https://epicentre.msf.org/la-crise-de-borno-nigeria-mortalite-et-malnutrition-dans-les-zones-dintervention-de-msf-masson-s</loc><lastmod>2019-01-22T13:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/borno-crisis-nigeria-mortality-and-malnutrition-areas-msf-intervention-masson-s-video-2017-fr" /></url>
<url><loc>https://epicentre.msf.org/evaluation-sanitaire-dans-les-camps-de-refugies-autour-de-mossoul-irak-haidar-m-video-2017-en</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/health-assessment-refugee-camps-around-mosul-iraq-haidar-m-video-2017-en" /></url>
<url><loc>https://epicentre.msf.org/evaluation-sanitaire-et-surveillance-dans-les-camps-de-refugies-dans-le-nord-de-louganda-ardiet-d</loc><lastmod>2019-01-22T13:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/health-assessment-and-surveillance-refugee-camps-northern-uganda-ardiet-d-video-2017-fr" /></url>
<url><loc>https://epicentre.msf.org/grece-violence-sante-mentale-et-acces-linformation-des-refugies-ben-farhat-j-video-2017-fr</loc><lastmod>2019-01-22T13:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/refugees-greece-violence-mental-health-and-access-information-ben-farhat-j-video-2017-fr" /></url>
<url><loc>https://epicentre.msf.org/essai-rifavirenz-interaction-entre-la-rifampicine-haute-dose-et-lefavirenz-chez-les-patients-avec</loc><lastmod>2019-01-22T14:37Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/rifavirenz-trial-interaction-between-high-dose-rifampicin-and-efavirenz-pulmonary-tuberculosis-and" /></url>
<url><loc>https://epicentre.msf.org/epidemie-de-fievre-de-la-vallee-du-rift-au-niger-soumah-video-2017-fr</loc><lastmod>2019-01-22T17:04Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/rift-valley-fever-epidemic-niger-soumah-video-2017-fr" /></url>
<url><loc>https://epicentre.msf.org/validation-transculturelle-dune-echelle-de-depistage-de-la-souffrance-chez-les-enfants-ages-de-6-36</loc><lastmod>2019-01-22T17:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cross-cultural-validation-screening-tool-psychological-difficulties-children-aged-6-36-months" /></url>
<url><loc>https://epicentre.msf.org/vaccins-oraux-contre-le-cholera-transformer-des-produits-anciens-en-solutions-nouvelles-pour-les</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/oral-cholera-vaccines-transforming-old-products-new-solutions-neglected-populations-luquero-f-video" /></url>
<url><loc>https://epicentre.msf.org/difficultes-dacces-au-diagnostic-et-au-traitement-de-la-leishmaniose-viscerale-chez-les</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/barriers-access-visceral-leishmaniasis-diagnosis-and-care-among-seasonal-workers-and-farmers-tigray" /></url>
<url><loc>https://epicentre.msf.org/plus-faible-retention-en-soins-lorsque-les-arv-sont-inities-avec-des-cd4-500-cellules-ml-andrieux</loc><lastmod>2019-01-31T14:32Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/lower-retention-care-when-art-are-initiated-cd4500-cells-ml-andrieux-meyer-i-poster-2017" /></url>
<url><loc>https://epicentre.msf.org/connaissance-de-la-charge-virale-et-de-lechec-du-traitement-chez-les-patients-sous-traitement</loc><lastmod>2019-01-31T14:33Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/knowledge-viral-load-and-treatment-failure-amongst-patients-second-line-and-third-line" /></url>
<url><loc>https://epicentre.msf.org/resultats-et-effets-secondaires-chez-les-patients-sous-arv-depuis-plus-de-10-ans-malawi-mathabire</loc><lastmod>2019-01-31T14:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/outcomes-and-side-effects-patients-art-more-10-years-malawi-mathabire-sc-poster-2017" /></url>
<url><loc>https://epicentre.msf.org/surveillance-de-la-charge-virale-avec-samba-1-une-methode-poc-au-plus-pres-du-patient-semi</loc><lastmod>2019-01-31T14:40Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/viral-load-monitoring-samba-1-semi-quantitative-nearly-point-care-method-arua-rural-district-uganda" /></url>
<url><loc>https://epicentre.msf.org/impact-du-depistage-elargi-et-des-methodes-poc-sur-le-diagnostic-du-nourrisson-et-linitiation-du</loc><lastmod>2019-01-31T14:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/impact-expanded-screening-and-poc-infant-diagnosis-and-art-initiation-nikuze-poster-2017" /></url>
<url><loc>https://epicentre.msf.org/incidence-du-vih-cascade-et-depistage-parmi-les-meres-dans-louest-du-kenya-nikuze-poster-2017-en</loc><lastmod>2019-01-31T14:41Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/hiv-incidence-cascade-and-testing-among-mothers-western-kenya-nikuze-poster-2017" /></url>
<url><loc>https://epicentre.msf.org/traitement-de-lhepatite-c-dans-une-clinique-de-soins-primaires-karachi-au-pakistan-dans-le-contexte</loc><lastmod>2019-01-31T14:43Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/hepatitis-c-treatment-primary-care-clinic-high-hcv-burden-setting-karachi-pakistan-donchuk-d-poster" /></url>
<url><loc>https://epicentre.msf.org/taux-de-mortalite-eleve-chez-les-enfants-de-faible-poids-lie-aux-doses-supratherapeutiques-de</loc><lastmod>2019-01-31T14:44Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/high-fatality-low-weight-children-related-supratherapeutic-doses-paracetamol-countries-unrestricted" /></url>
<url><loc>https://epicentre.msf.org/portfolio/la-malnutrition</loc><lastmod>2019-03-26T17:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/malnutrition" /></url>
<url><loc>https://epicentre.msf.org/prevalence-et-acces-aux-soins-conan-n-abstract-2017-en</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/prevalence-and-linkage-care-conan-n-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/comprendre-lechec-virologique-chez-les-adolescents-vivant-avec-le-vih-dans-le-district-de-0</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/understanding-virological-failure-adolescents-living-hiv-chiradzulu-district-malawi-schramm-b" /></url>
<url><loc>https://epicentre.msf.org/diagnostic-precoce-du-jeune-enfant-realites-et-enjeux-maman-d-abstract-2017-en</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/early-infant-diagnosis-field-practices-and-challenges-maman-d-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/controle-des-infections-prescrire-sans-nuire-lere-de-lantibioresistance-langendorf-c-abstract-2017</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/infection-control-prescribe-while-doing-no-harm-era-antibiotic-resistance-langendorf-c-abstract" /></url>
<url><loc>https://epicentre.msf.org/quand-et-comment-changer-de-strategie-dans-une-epidemie-de-paludisme-aweil-soudan-du-sud-2016-0</loc><lastmod>2019-02-05T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/when-and-how-change-strategy-malaria-epidemic-aweil-south-sudan-2016-nadimpalli-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/chimioprevention-du-paludisme-saisonnier-histoire-justification-et-enjeux-coldiron-m-abstract-2017</loc><lastmod>2019-01-20T16:07Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/seasonal-malaria-chemoprevention-history-rationale-and-challenges-coldiron-m-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/la-crise-de-borno-nigeria-mortalite-et-malnutrition-dans-les-zones-dintervention-de-msf-masson-s-0</loc><lastmod>2019-01-20T16:10Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/borno-crisis-nigeria-mortality-and-malnutrition-areas-msf-intervention-masson-s-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/evaluation-sanitaire-dans-les-camps-de-refugies-autour-de-mossoul-irak-haidar-m-abstract-2017-en</loc><lastmod>2019-01-20T16:58Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/health-assessment-refugee-camps-around-mosul-iraq-haidar-m-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/evaluation-sanitaire-et-surveillance-dans-les-camps-de-refugies-dans-le-nord-de-louganda-ardiet-d-0</loc><lastmod>2019-01-20T17:01Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/health-assessment-and-surveillance-refugee-camps-northern-uganda-ardiet-d-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/grece-violence-sante-mentale-et-acces-linformation-des-refugies-ben-farhat-j-abstract-2017-en</loc><lastmod>2019-01-20T17:07Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/refugees-greece-violence-mental-health-and-access-information-ben-farhat-j-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/diagnostic-de-la-tuberculose-chez-lenfant-bonnet-m-abstract-2018-en</loc><lastmod>2019-01-17T13:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/diagnostic-tuberculosis-children-bonnet-m-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/essai-rifavirenz-interaction-entre-la-rifampicine-haute-dose-et-lefavirenz-chez-les-patients-avec-0</loc><lastmod>2019-01-20T17:12Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/rifavirenz-trial-interaction-between-high-dose-rifampicin-and-efavirenz-pulmonary-tuberculosis-0" /></url>
<url><loc>https://epicentre.msf.org/epidemie-de-fievre-de-la-vallee-du-rift-au-niger-soumah-abstract-2017-en</loc><lastmod>2019-01-20T17:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/rift-valley-fever-epidemic-niger-soumah-abstract-2017" /></url>
<url><loc>https://epicentre.msf.org/validation-transculturelle-dune-echelle-de-depistage-de-la-souffrance-chez-les-enfants-ages-de-6-0</loc><lastmod>2019-01-20T17:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/cross-cultural-validation-screening-tool-psychological-difficulties-children-aged-6-36-months-0" /></url>
<url><loc>https://epicentre.msf.org/vaccins-oraux-contre-le-cholera-transformer-des-produits-anciens-en-solutions-nouvelles-pour-les-0</loc><lastmod>2019-01-20T17:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/oral-cholera-vaccines-transforming-old-products-new-solutions-neglected-populations-luquero-f" /></url>
<url><loc>https://epicentre.msf.org/difficultes-dacces-au-diagnostic-et-au-traitement-de-la-leishmaniose-viscerale-chez-les-0</loc><lastmod>2019-01-20T17:31Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/barriers-access-visceral-leishmaniasis-diagnosis-and-care-among-seasonal-workers-and-farmers-0" /></url>
<url><loc>https://epicentre.msf.org/journees-scientifiques/journee-scientifique-2017</loc><lastmod>2019-03-18T11:49Z</lastmod><changefreq>never</changefreq><priority>0.6</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/scientific-days/scientific-day-2017" /></url>
<url><loc>https://epicentre.msf.org/bacteriemie-dans-un-hopital-pediatrique-au-niger-langendorf-c-video-2018-fr</loc><lastmod>2019-01-22T11:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/bacterial-bloodstream-infections-pediatric-hospital-niger-langendorf-c-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/developpement-dun-test-diagnostique-pour-les-infections-pediatriques-page-al-abstract-2018-en</loc><lastmod>2019-01-17T13:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/development-diagnostics-pediatric-infections-page-al-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/traitement-de-lhepatite-c-dans-les-programmes-msf-loarec-abstract-2018-en</loc><lastmod>2019-01-17T13:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/treating-hepatitis-c-msf-programs-loarec-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/introduction-de-deux-nouveaux-medicaments-contre-la-tuberculose-resistante-huerga-h-abstract-2018</loc><lastmod>2019-02-05T13:16Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/introducing-two-new-drugs-resistant-tuberculosis-huerga-h-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/prophylaxie-antibiotique-en-reponse-une-epidemie-de-meningite-meningocoques-coldiron-m-abstract</loc><lastmod>2019-01-17T13:11Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/antibiotic-prophylaxis-response-meningococcal-meningitis-outbreak-coldiron-m-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/traitement-systematique-et-empirique-de-la-tuberculose-chez-les-patients-infectes-par-le-vih-et-0</loc><lastmod>2019-01-17T13:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/systematic-and-empirical-treatment-tuberculosis-hiv-advanced-infected-patients-muzoora-c-abstract" /></url>
<url><loc>https://epicentre.msf.org/mortalite-chez-les-rohingyas-en-2017-masson-s-abstract-2018-en</loc><lastmod>2019-01-17T13:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/mortality-among-rohingyas-2017-masson-s-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/acces-aux-soins-de-sante-dans-le-nord-du-cameroun-gignoux-e-abstract-2018-en</loc><lastmod>2019-01-17T13:21Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/access-health-care-north-cameroon-gignoux-e-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/sante-mentale-mossoul-irak-ben-farhat-j-abstract-2018-en</loc><lastmod>2019-01-17T13:05Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/mental-health-mosul-iraq-ben-farhat-j-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/modelisation-de-lepidemie-de-cholera-au-yemen-camacho-abstract-2018-en</loc><lastmod>2019-01-17T13:18Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/modelling-cholera-outbreak-yemen-camacho-abstract-2018" /></url>
<url><loc>https://epicentre.msf.org/journees-scientifiques/journee-scientifique-2019</loc><lastmod>2019-04-23T10:10Z</lastmod><changefreq>never</changefreq><priority>0.6</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/scientific-days/scientific-day-2019" /></url>
<url><loc>https://epicentre.msf.org/apport-nutritionnel-chez-les-femmes-enceintes-au-niger-isanaka-s-video-2018-en</loc><lastmod>2019-01-22T11:31Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/nutritional-support-pregnant-women-niger-isanaka-s-video-2018-en" /></url>
<url><loc>https://epicentre.msf.org/diagnostic-de-la-tuberculose-chez-lenfant-bonnet-m-video-2018-fr</loc><lastmod>2019-01-22T11:33Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/diagnostic-tuberculosis-children-bonnet-m-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/developpement-dun-test-diagnostique-pour-les-infections-pediatriques-page-al-video-2018-fr</loc><lastmod>2019-01-22T11:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/development-diagnostics-pediatric-infections-page-al-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/traitement-de-lhepatite-c-dans-les-programmes-msf-loarec-video-2018-fr</loc><lastmod>2019-01-22T11:34Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/treating-hepatitis-c-msf-programs-loarec-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/nos-concretisations/cholera</loc><lastmod>2019-04-11T12:04Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/our-achievements/cholera" /></url>
<url><loc>https://epicentre.msf.org/epicentre/centre-de-recherche-en-ouganda</loc><lastmod>2019-04-08T09:53Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/research-center-uganda" /></url>
<url><loc>https://epicentre.msf.org/journees-scientifiques/journee-scientifique-niger-2018</loc><lastmod>2019-03-18T10:30Z</lastmod><changefreq>never</changefreq><priority>0.6</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/scientific-days/scientific-day-niger-2018" /></url>
<url><loc>https://epicentre.msf.org/portfolio/lulcere-de-buruli</loc><lastmod>2019-03-27T16:02Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/buruli-ulcer" /></url>
<url><loc>https://epicentre.msf.org/introduction-de-deux-nouveaux-medicaments-contre-la-tuberculose-resistante-huerga-h-video-2018-en</loc><lastmod>2019-01-22T11:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/introducing-two-new-drugs-resistant-tuberculosis-huerga-h-video-2018-en" /></url>
<url><loc>https://epicentre.msf.org/portfolio/la-leishmaniose-viscerale</loc><lastmod>2019-04-11T11:27Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/visceral-leishmaniasis" /></url>
<url><loc>https://epicentre.msf.org/portfolio/rotavirus</loc><lastmod>2019-04-11T12:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/rotavirus" /></url>
<url><loc>https://epicentre.msf.org/epicentre/competences</loc><lastmod>2019-04-11T08:11Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/competencies" /></url>
<url><loc>https://epicentre.msf.org/epicentre/competences/lethique</loc><lastmod>2019-04-08T10:01Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/competencies/ethics" /></url>
<url><loc>https://epicentre.msf.org/portfolio/le-paludisme</loc><lastmod>2019-04-11T12:07Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/malaria" /></url>
<url><loc>https://epicentre.msf.org/traitement-systematique-et-empirique-de-la-tuberculose-chez-les-patients-infectes-par-le-vih-et-un</loc><lastmod>2019-01-22T11:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/systematic-and-empirical-treatment-tuberculosis-hiv-advanced-infected-patients-muzoora-c-video-2018" /></url>
<url><loc>https://epicentre.msf.org/mortalite-chez-les-rohingyas-en-2017-masson-s-video-2018-fr</loc><lastmod>2019-01-22T11:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/mortality-among-rohingyas-2017-masson-s-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/acces-aux-soins-de-sante-dans-le-nord-du-cameroun-gignoux-e-video-2018-fr</loc><lastmod>2019-01-22T11:33Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/access-health-care-north-cameroon-gignoux-e-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/sante-mentale-mossoul-irak-ben-farhat-j-video-2018-fr</loc><lastmod>2019-02-06T16:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/mental-health-mosul-iraq-ben-farhat-j-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/modelling-cholera-outbreak-yemen-camacho-videos-2018</loc><lastmod>2019-01-22T11:35Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/modelling-cholera-outbreak-yemen-camacho-videos-2018" /></url>
<url><loc>https://epicentre.msf.org/politique-de-cookies-epicentre</loc><lastmod>2019-03-22T21:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre-cookie-policy" /></url>
<url><loc>https://epicentre.msf.org/portfolio/fievre-jaune</loc><lastmod>2019-04-11T12:13Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/yellow-fever" /></url>
<url><loc>https://epicentre.msf.org/fiche-dinformation-essai-clinique-fievre-jaune-en</loc><lastmod>2019-03-20T16:02Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/fact-sheet-yellow-fever-clinical-trial" /></url>
<url><loc>https://epicentre.msf.org/actualites/doses-fractionnees-vaccin-fievre-jaune</loc><lastmod>2019-04-15T07:48Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/yellow-fever-vaccine-fractional-dose" /></url>
<url><loc>https://epicentre.msf.org/epicentre/faq</loc><lastmod>2019-04-11T08:14Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/faq" /></url>
<url><loc>https://epicentre.msf.org/portfolio/sante-mentale</loc><lastmod>2019-04-11T11:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/mental-health" /></url>
<url><loc>https://epicentre.msf.org/objectifs-populations-en-situation-precaire</loc><lastmod>2019-03-27T23:33Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/course-outline-populations-precarious-situations" /></url>
<url><loc>https://epicentre.msf.org/objectifs-reponse-aux-epidemies</loc><lastmod>2019-03-27T23:24Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/course-outline-response-epidemics" /></url>
<url><loc>https://epicentre.msf.org/epicentre/chiffres-cles</loc><lastmod>2019-03-28T00:05Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/key-figures" /></url>
<url><loc>https://epicentre.msf.org/nos-concretisations/trypanosomiase-humaine-africain</loc><lastmod>2019-04-11T13:23Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/our-achievements/human-african-trypanosomiasis" /></url>
<url><loc>https://epicentre.msf.org/donnees-personnelles</loc><lastmod>2019-02-20T10:46Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/personal-data" /></url>
<url><loc>https://epicentre.msf.org/toxicite-nifurtimox-melarsoprol-therapie-combineerapport-2000-en</loc><lastmod>2019-03-14T09:26Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/toxicity-combination-therapy-nifurtimox-melarsoprolreport-2000" /></url>
<url><loc>https://epicentre.msf.org/portfolio/evaluation-de-la-sante-de-la-population</loc><lastmod>2019-04-11T11:15Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/portfolio/population-health-assesments" /></url>
<url><loc>https://epicentre.msf.org/epicentre/centre-de-recherche-au-niger</loc><lastmod>2019-04-11T08:09Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/research-center-niger" /></url>
<url><loc>https://epicentre.msf.org/epicentre/mission</loc><lastmod>2019-04-08T09:51Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/mission" /></url>
<url><loc>https://epicentre.msf.org/epicentre/organisation-et-financement</loc><lastmod>2019-04-12T08:20Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/organisation-and-funding" /></url>
<url><loc>https://epicentre.msf.org/actualites/etude-sur-la-connaissance-du-statut-positif-vih-au-kenya</loc><lastmod>2019-04-15T07:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/news/hiv-status-awareness-study-kenya" /></url>
<url><loc>https://epicentre.msf.org/etude-de-sensibilisation-au-statut-vih-kenya-2018-en</loc><lastmod>2019-02-14T11:17Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/hiv-status-awareness-study-kenya-2018" /></url>
<url><loc>https://epicentre.msf.org/epicentre/nos-partenaires</loc><lastmod>2019-04-11T11:51Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/our-partners" /></url>
<url><loc>https://epicentre.msf.org/epicentre/notre-approche-de-lepidemiologie/politique-sur-les-essais-cliniques-depicentre</loc><lastmod>2019-03-25T17:19Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/epicentre/our-approach-epidemiology/epicentre-policy-clinical-trials" /></url>
<url><loc>https://epicentre.msf.org/journees-scientifiques/journee-scientifique-ouganda-2017</loc><lastmod>2019-03-18T10:36Z</lastmod><changefreq>never</changefreq><priority>0.6</priority><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/scientific-days/scientific-day-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/comprendre-lechec-virologique-chez-les-adolescents-seropositifs-est-ce-un-veritable-echec</loc><lastmod>2019-03-01T12:28Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/understanding-virological-failure-hiv-positive-adolescents-it-true-treatment-failure-or-poor" /></url>
<url><loc>https://epicentre.msf.org/pecheurs-et-communautes-de-pecheurs-en-afrique-de-lest-la-population-la-plus-risque-detre-infectee</loc><lastmod>2019-03-01T12:29Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/fishermen-and-fishing-communities-east-africa-most-risk-population-acquiring-hiv-infection-results" /></url>
<url><loc>https://epicentre.msf.org/contribution-des-etudes-dimpact-du-vih-sur-la-population-aux-strategies-de-soins-experience-de-6</loc><lastmod>2019-03-01T12:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/contribution-hiv-population-impact-studies-care-strategies-experience-6-msf-african-projects-mamam" /></url>
<url><loc>https://epicentre.msf.org/traitement-art-base-de-lopinavir-pour-les-enfants-vih-dans-le-monde-etude-living-adong-j-abstract</loc><lastmod>2019-03-18T17:02Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/lopinavir-based-art-hivi-nfected-children-globally-living-study-adong-j-abstract-uganda-2017" /></url>
<url><loc>https://epicentre.msf.org/rifatox-peut-en-toute-securite-doubler-la-dose-de-rifampicine-pour-reduire-la-duree-du-traitement</loc><lastmod>2019-02-22T10:53Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/rifatox-it-safe-double-dose-rifampicin-shorten-tuberculosis-treatment-duration-atwine-d-abstract" /></url>
<url><loc>https://epicentre.msf.org/journee-scientifique-video-ouganda-2017</loc><lastmod>2019-03-18T16:59Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/uganda-scientific-day-video" /></url>
<url><loc>https://epicentre.msf.org/epicentre/equipe</loc><lastmod>2019-02-14T15:13Z</lastmod><changefreq>never</changefreq></url>
<url><loc>https://epicentre.msf.org/antibiotiques-de-routine-dans-le-traitement-de-la-malnutrition-aigue-severe-non-compliquee-au-niger</loc><lastmod>2019-01-22T11:36Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/routine-antibiotics-treatment-uncomplicated-severe-acute-malnutrition-niger-chokote-b-video-2018-fr" /></url>
<url><loc>https://epicentre.msf.org/prophylaxie-antibiotique-en-reponse-une-epidemie-de-meningite-meningocoques-coldiron-m-video-2018</loc><lastmod>2019-01-22T11:30Z</lastmod><changefreq>never</changefreq><xhtml:link rel="alternate" hreflang="en" href="https://epicentre.msf.org/en/antibiotic-prophylaxis-response-meningococcal-meningitis-outbreak-coldiron-m-video-2018-en" /></url>
<url><loc>https://epicentre.msf.org/prevalence-des-mycobacteries-atypiques-chez-des-patients-avec-suspicion-clinique-de-tuberculose-au</loc><lastmod>2019-02-05T13:16Z</lastmod><changefreq>never</changefreq></url>
</urlset>
